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Background. The cycle between diarrhea and undernutrition continues to underlie a vast 
proportion of under-five mortality and is the primary driver of long-term disability among 
children living in lower and middle-income countries (LMIC). Interventions aimed at 
reducing childhood stunting have not achieved desired results, highlighting the need for 
novel research and strategies to target this problem. There is increasing evidence that the 
gut microbiota are implicated in growth acquisition and sustaining intestinal barrier 
integrity in a manner that impacts immunity to and consequences of disease; however, 
these relationships have not yet been examined in large-scale studies of children living in 
LMIC.  
Objective. To evaluate relationships between the gut microbial community, child growth, 
diarrhea and enteric infections (Campylobacter spp) in a birth cohort of 271 children 
aged 0-24 months in Iquitos, Peru. 
Methods. Analyses were conducted on children participating in the multi-site cohort 
study entitled ‘The Interactions of Malnutrition & Enteric Infections: Consequences for 
Child Health and Development (MAL-ED).’ Data were contributed over two years by 
mothers and children living in a peri-urban riverine community in Amazonian Peru. 
Regular home-visits were conducted to ascertain anthropometric indices, illness history, 
and dietary habits. Length-for-age (LAZ) and weight-for-length (WLZ) Z-scores below -
2 were used to classify stunting and wasting, respectively. Fecal specimens were 
collected during routine surveillance visits at monthly intervals (N=6004) and 
additionally during each maternal report of diarrheal symptoms (N=2436). Culture 
methods, immunoassays and amplification methods were employed according to a 
unified MAL-ED protocol to identify a panel of over 40 protozoa, bacteria and viruses of 
 iii 
public health importance. Microbiota in fecal samples contributed at 6, 12, 18 and 24 
months were analyzed by polymerase chain reactions using primers to identify variable 
regions of bacterial 16S ribosomal RNA genes at the Gordon Laboratory at Washington 
University. Members were binned into operational taxonomic units (OTU) sharing ≥97% 
nucleotide sequence identity, producing bacterial communities differentiated at the 
species level which were then used to generate metrics of maturity (microbiota-for-age Z 
score; MAZ), diversity (Shannon, Simpson indices) and richness (CHAO1, Faith’s 
Phylogenetic Diversity). Multivariable regression was used to detect and describe 
population-averaged associations between microbial metrics, growth acquisition, illness 
and infection with a generalized estimating equations approach to adjust for within-child 
correlations over time.  Indicator species analysis (ISA) was employed to identify 
particular gut taxa whose presence and abundance was statistically indicative of 
phenotypes of interest.  
Results. Two-thirds of children (67%) were stunted and 9% of children experienced 
wasting before their 2nd birthday. Microbial diversity and richness increased significantly 
with age and weaning, and were suppressed by breastmilk exposure. In the first two years 
of life, we detected a suggestive relationship between microbial maturity and WLZ, but 
did not observe evidence of associations between microbial maturity, diversity or 
richness with LAZ in the full cohort. LAZ at birth was significantly associated with MAZ 
score throughout follow-up (β=0.10, p=0.012) and children born stunted had 
significantly lower gut microbial diversity and richness (Shannonβ=-0.19, CHAO1 =-
9.75; p-values <0.05) from birth to two years of age. In this subgroup, we additionally 
observed that children weaned before 24m of age experienced significantly pronounced 
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deficits in microbial diversity and richness acquisition relative to those with continued 
breastfeeding.  
Nearly all children (96%) experienced diarrhea during follow-up. Odds of being 
severely stunted increased by 8% with each additional diarrheal episode throughout the 
first two years of life (OR=1.08; p<0.001). Cumulative diarrheal frequency, duration and 
severity were associated with significant reductions in microbial indices (p<0.05), and we 
observed evidence of enduring deficits beyond 1m after exposure. Children who were 
born stunted experienced greater insults to microbial diversity per diarrheal episode than 
those children who were not (Interaction terms: Shannon β =-0.04, p=0.037; Simpson β 
=-0.01, p=0.032). Time elapsed since last diarrheal episode was associated with recovery 
of Shannon (β =0.02, p=0.03) and phylogenetic diversity (β =0.11, p<0.01) and we 
detected evidence that this regeneration process was significantly slower among severely 
stunted children. Lower diversity and richness were associated with increased subsequent 
diarrheal incidence; a 1-unit increase in the Shannon and Simpson’s Diversity scales at 
6m corresponding to a mean reduction of 1.3 and 3.4 diarrheal episodes from 6-24m of 
age, respectively. 
By two years of age, 251 (93%) of all children in the cohort had Campylobacter 
present in asymptomatic stools, and 221 (82%) experienced infection with diarrhea. 
Asymptomatic infection was associated with reduced LAZ concurrently and at 3, 6, and 
9m thereafter (β=0.02, p<0.01 across all time points). Frequency of Campylobacter-
positive diarrhea was associated with a concurrent reduction in -0.03 LAZ (p=0.002), 
independently from all-cause diarrhea. Asymptomatic Campylobacter infections were 
associated with changes to the gut microbial environment. Infection was associated with 
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increased microbial diversity and richness metrics, and we identified 21 taxa indicative of 
being in the highest or lowest quartile of infection from birth to two years of age. Of 
these, seven indicator species showed suggestive evidence of a link with LAZ 
concurrently and 1m thereafter.  
Conclusions. This study provided evidence of associations between the gut microbial 
community, anthropometric indices, and enteric infections in a population of children 
experiencing the classical cycle of diarrhea and undernutrition. This is the first study to 
our knowledge to interrogate these pathways longitudinally in a large, representative 
sample of infants in LMIC. Our findings generate questions regarding the precise causal 
mechanisms underlying the observed associations, and should inform subsequent efforts 
to identify specific and actionable targets to interrupt pathways compounding childhood 
morbidity and mortality in LMIC. 
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Chapter 1: Introduction 
The intestinal tract constitutes the largest immune interface between the human body 
and the outer environment, and is responsible for maintaining immunological tolerance to 
trillions of microbes while recognizing and defending against invading pathogens.  The 
composition and assembly of the dense community of microbiota populating the human 
gut and its collective genetic make-up, referred to as the microbiome, is increasingly 
implicated in metabolism and digestion, host defense against pathogens, and maintenance 
and modulation of immunity.  In recent years, the influence of the gut microbial 
community on these critical functions has been convincingly demonstrated in laboratory 
settings. Animal models have been used to manipulate the gut bacterial community to 
induce obesity and undernutrition, influence a range of infectious and chronic 
inflammatory diseases, and alter antibody responses to challenge with infection and 
vaccination. A growing body of evidence conducted in humans corroborates these 
observations, illustrating differences in gut microbial composition according to varying 
nutritional profiles and chronic and infectious disease histories and outcomes.  
These developments are of particular interest to the public health community for 
several reasons.  It is widely accepted that malnutrition, including both over and 
underweight, blunts immunity to infection, and increased burden of infection is 
associated with compromised immune responses and growth trajectories thereafter.  
While the impacts of interactions between infection, immunity and nutrition have been 
extensively described worldwide, interventions aimed at interrupting this cycle have 




mechanisms remains incomplete. Consequences of this gap in knowledge for child health 
and survival are profound, with diarrheal disease and chronic undernutrition continuing to 
drive a vast proportion of death and long-term disability among children younger than 5 
years globally. The possibility that the gut microbial community may be implicated in 
these relationships is therefore promising for the development of novel interventions in 
infectious disease prevention and management, vaccine development, and nutritional 
support to avert this burden in a range of developmental and epidemiologic settings.  
This line of enquiry, while encouraging, remains in a nascent stage in the pipeline of 
public health research.  In lower income settings and particularly among young children, 
data from human studies is limited.  The majority of research has been concentrated in 
adults living in high-income settings, with large-scale studies in Europe and the USA 
generating enthusiasm for the use of microbiome data to inform personalized medicine.  
Comparative lack of research in vulnerable communities and lower and middle-income 
countries (LMIC) risks compounding existing inequities in access to novel approaches to 
improving health and quality of life.  Where studies have been conducted in this 
demographic, they have been predominantly cross-sectional and limited by extremely 
small sample sizes.  There remains a lack of consensus on what constitutes a healthy 
versus unfavorable gut community, and how this can be compared across populations that 
differ vastly in their dietary and environment exposures. Studies with larger and more 
representative samples are needed to provide a more complete description of population-
level behaviors and exposures influencing microbial succession in the gut community of 
infants and young children, and the potential consequences of different microbial profiles 




mechanisms and temporality of proposed relationships between the gut microbiota, 
enteric infections, immune responses and growth trajectories will be crucial to generating 
and testing hypotheses. Advancement of these enquiries from experimental laboratory 
models to epidemiologic studies at the population level will be critical to understanding 
whether and how this field may yield therapeutic interventions for child survival and 
quality of life in LMIC.   
This dissertation aims to help address these gaps by exploring associations between 
the bacterial environment of the developing infant gut and indicators of child growth, 
enteric infection and diarrheal illness in a large birth cohort in the Peruvian Amazon. The 
following chapters will provide a summary of existing literature informing this work; a 
theoretical framework illustrating the potential role of the gut microbiota in the cycle of 
enteropathy and undernutrition; and three distinct sets of analyses interrogating 
relationships between gut microbial diversity and composition, growth acquisition, and 
enteric infection and disease from birth to two years of age. We believe that using a large, 
community-based longitudinal cohort to further characterize these relationships will be an 
important contribution to the goal of better understanding, and ultimately improving 
interventions to promote health and growth during a crucial window for child survival 
and development. 
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Chapter 2: Background & Rationale 
The case of the leaky bucket: interactions between undernutrition, immunity 
and infection in young children  
Despite recent reductions in child mortality, the ongoing toll of the cycle between 
diarrhea and undernutrition on child health and survival remains staggering. Diarrhea is 
estimated to directly account for the loss of  up to 700,000 among children under 5 years 
of age (U5) worldwide (1,2).  Furthermore, it is estimated that maternal and child 
undernutrition cause over 3 million child deaths, accounting for nearly half of all U5 
mortality annually (3).  Not reflected in these global mortality estimates is extent of 
morbidity and loss of human potential arising from the burden of repeated enteric 
infections (4). Indeed, experts have recently estimated diarrheal disease to be the leading 
cause of death and long-term disability among children under 5 years of age worldwide, 
arguing that focus on mortality and short-term morbidity has substantially and 
systematically underestimated the profound consequences of repeated diarrheal disease 
for intestinal function, child growth and overall developmental potential (5,6). New 
estimates accounting for these sequelae increased the number of disability-adjusted life-
years lost to diarrhea by nearly 40% among children under 5, to over 55 million annually 
(5). 
Interaction between undernutrition and infection was first formally described in a 
seminal paper by Nevin Scrimshaw, Carl Taylor and John Gordon in 1959 (7). During the 
decades that followed, ongoing work by Scrimshaw and others provided convincing 
evidence of synergistic interactions between undernutrition and infection, illustrating that 
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the additive effects of the two conditions were more detrimental to human health than the 
sum of their separate consequences (8).  An analogy of a leaky bucket was used to 
describe the efforts of pouring nutritional support into individuals whose infection 
profiles were concurrently resulting in nutritional losses; and as a result, calls were made 
for integrated interventions to account for these interactions in improving health (8,9).   
It is difficult to imagine a better example of the leaky bucket than the cycle between 
undernutrition and enteric infections, specifically.  It is now widely accepted that diarrhea 
impairs growth, and undernutrition is linked to increased incidence, duration, and severity 
of diarrhea.  Moreover, there are consequences of repeated or chronic enteric infections, 
even in the absence of diarrheal symptoms, for intestinal function and subsequent gains in 
growth.  This section will summarize what is known about how enteric infections and 
undernutrition exacerbate one another to provide context for the research questions 
addressed in this study.   
Diarrhea and enteric infections impair growth.  Monitoring of illness history and 
growth curves among children in Guatemala provided convincing evidence of the link 
between diarrhea and enteric infections and growth faltering in the 1960s (10). 
Subsequent work across African, South Asian and Latin American settings (11–19) 
confirmed that frequency and duration of diarrheal disease is associated with reductions 
in weight and height gains, particularly during early childhood when growth trajectories 
are most plastic. Beyond acute symptomatic disease, murine models and human studies 
have demonstrated growth suppression associated with periods of infection that occur in 
the absence of or endure well beyond diarrheal symptoms (20–24). Diarrhea is estimated 
to be the single most important infectious disease driving undernutrition (3), accounting 
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for up to 25% of stunting worldwide (25).  However, these estimates do not include the 
nutritional consequences of chronic or repeated enteric infections without overt diarrheal 
symptoms, suggesting that they underestimate the true contribution of these conditions to 
impaired growth worldwide.  
Undernutrition affects immunity to disease.  Undernutrition, in turn, increases 
vulnerability to infectious diseases and their consequences. Initial observations of this 
relationship described links between protein deficiency, or kwashiorkor, with decreased 
antibody formation in infants and young children (26).  A large body of research 
conducted since has described various pathways through which both protein-energy 
malnutrition (PEM) and micronutrient deficiencies (MND) impair immune development 
and function.  PEM affects innate and adaptive immune responses by depleting 
lymphocyte stores, reducing T-cell differentiation and antibody production, and 
diminishing both complement proteins and inflammatory cytokines during infection (27).  
The relationship between MND and immunity is illustrated by Vitamin A deficiency, 
which is strongly linked to increased infection and child mortality. Vitamin A is now 
understood to play a key role in maintaining epithelial and mucosal barriers, a crucial, 
first-line component of immunity, and in promoting T- and B-cell signaling and 
proliferation necessary for mounting adaptive responses (26–30).  Other micronutrients 
with demonstrated links to immune function include Vitamin E, which improves vaccine 
responses by promoting T-cell function; and zinc, which has been shown to reduce 
severity and duration of diarrheal disease (4,26–28).   
Evidence of compromised defenses against infectious diseases, including malaria, 
tuberculosis, diarrheal disease, pneumonia, HIV, and measles, highlights the extent of 
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childhood morbidity and mortality driven by underlying undernutrition (3,26).  The most 
consistent literature illustrating this link has been generated in the field of enteric disease; 
numerous studies conducted in both clinical and community-based settings have 
consistently identified child growth deficits as risk factors for incidence, severity, 
duration and survival rates of infection with enteropathogens of public health importance 
(31–38).  
Consequences for child health & development.  Taken together, these studies provide 
convincing evidence of the synergistic, cyclical relationships between enteric infection, 
compromised immunity, and undernutrition.  But why does this matter?   
These interactions give rise to and exacerbate inequities in health and economic 
opportunity worldwide.  Risk factors for undernutrition and enteric infections - such as 
food insecurity, poor access to water and sanitation resources, and vulnerability to 
climate events- disproportionately affect the world’s poorest and most vulnerable 
populations and provide the ideal conditions for this cycle to compound poverty and 
disease for coming generations. As described, a wealth of data links growth faltering to 
negative health, social and economic outcomes (39); what has also been demonstrated is 
that the window to most effectively avert these consequences may be quite small. 
Difficulties in recovering linear growth after infancy and early childhood are well-
described, and have led to the identification of “the first 1000 days” spanning conception 
to 24 months of age as a critical window for intervention (40–42).  Further, while the 
mortality rates associated with acute undernutrition or wasting are higher, the long-term 
population impacts of chronic undernutrition are relatively greater, and there is a 
comparative paucity of prevention and treatment programs to tackle it (3,5). Similarly, 
 8 
while mortality due to acute diarrheal disease has decreased in recent years, morbidity 
has persisted (4,5,43) and is thought to drive enduring deficits in cognitive function and 
school performance (44–46).  A growing body of research also links both enteric disease 
and stunting in early life to increased risk of chronic diseases in adulthood (43).  The 
rising prevalence of conditions like overweight and obesity, cardiovascular disease, and 
diabetes, is a formidable challenge to health systems in LMIC and will further compound 
the resource shortages they face relative to wealthier nations. 
The underwhelming impacts of considerable intellectual and material resources that 
have been allocated to interventions must also be noted. Disappointing results of water, 
sanitation, nutrition and enteric disease control programs are an obstacle to maximizing 
health gains and use of valuable financial and human resources in affected populations 
(47).  One important example is lower vaccine efficacy in areas of high undernutrition 
and enteric disease.  Ongoing research is being conducted to promote a better 
understanding of risk factors for vaccine failure in developing country settings, but it is 
thought that protein-energy malnutrition and micronutrient deficiency, stunting, infection 
in early life, and mucosal intestinal damage are all implicated (48–50).   Furthermore, 
recent evaluations of rigorously implemented water, sanitation and hygiene interventions 
in Sub-Saharan Africa and South Asia have yielded deeply discouraging results 
demonstrating little to no effect on diarrheal disease incidence or child growth (51).   
Given the amount of mortality and disability driven by these conditions, and the 
failure of programs to effectively interrupt this cycle and achieve gains in child growth, 
there is an ethical imperative in the public health community to devise novel strategies 
targeting these pathways. 
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Novel research & emerging frameworks  
In response to these enduring challenges, the public health community has called for a 
rethinking of the causal pathways driving this cycle and a redoubling of efforts to 
interrupt it (5).  Within this arena there has been a great deal of literature focusing on the 
structure and function of human intestinal tract, or the site at which these interactions 
occur.  Four distinct layers of defense are maintained in the human gut: a mechanical 
barrier of epithelial cells separating intestinal contents from the inner host; a mucosal 
barrier comprised of antimicrobial epithelial cell secretions; an immunological barrier of 
innate and adaptive immune cells in the mucosa and subepithelia; and an ecological 
barrier comprised of gut microbiota deterring colonization by enteropathogens (30,47). 
The next two sections will summarize the existing literature and outline the hypothesized 
role of two distinct but related theories of gut barrier disruption, environmental 
enteropathy and alterations to intestinal microbiota, in exacerbating the burden of 
undernutrition and enteropathy.  
Environmental enteropathy 
During the same era when the cycle of infection and undernutrition was first 
described, it was also observed that people living in areas of endemic enteric infection 
exhibited abnormal morphologies of the small intestine (52,53).  The condition, coined 
‘tropical enteropathy,’ described flattened intestinal villi and increased inflammation 
largely in the absence of any perceptible symptoms.  In subsequent years, comparison of 
these observations across geographic and developmental settings confirmed the 
hypothesis that morphologic gut alterations occur in populations with poor hygienic 
conditions and high burden of enteric infections, and can be reversible upon relocation to 
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settings with access to hygiene resources, safe water and sanitation infrastructure (47).  
These physiologic, anatomic and functional changes of the gut are now referred to as 
environmental enteropathy (EE) and are posited to play an important role in the cycle of 
poverty, undernutrition, compromised immunity, and long-term cognitive and physical 
impairment in LMIC (54).  This hypothesis can be summarized as follows:  infants living 
in poor hygienic conditions develop EE early in life, experiencing increased gut 
permeability and possibly malabsorption, which then drive local and systemic immune 
activation leading to impaired immunological, nutritional and cognitive development 
(47,54).   
Indeed, there is evidence that EE can help explain interactions between undernutrition 
and intestinal infections.  Chronic stimulation of the immunological barrier by 
enteropathogens results in over-active innate responses, which in turn may lead to 
increased permeability of the mechanical barrier and reduced vaccine efficacy (55).  
Increased epithelial permeability can then results in translocation of microbial products, 
and xenobiotics, including but not limited to food antigens, from gut contents into general 
circulation driving systemic inflammation, which is implicated in a range of deleterious 
health conditions (30,47,54,56). Evidence of the linkage of inflammation and gut 
permeability to nutritional attainment in LMIC is increasing.  Studies in a population of 
Gambian infants reveal associations between markers of intestinal permeability (IP) and 
resulting microbial translocation (MT) with significant growth faltering (57–60).  While 
infants exhibited barrier function comparable to UK participants at 2 months of age, IP 
and MT were found to increase substantially in the Gambian group by 15 months, 
accompanied by negative trends in linear and ponderal growth.  The two conditions were 
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estimated to account for 51-56% of linear growth impairment during this critical window 
(43,57,60). Analysis of fecal samples of over 500 children in a large, multi-site cohort 
study (MAL-ED) found that biomarkers of intestinal inflammation were associated with 
subsequent linear growth faltering, with children in the highest category of inflammation 
growing an average of 1.1cm less than those in the lowest (61).  Further analyses 
conducted at two of eight MAL-ED sites, Peru and Tanzania, revealed a significant 
association between the kynurenine-tryptophan ratio, a marker of systemic inflammation, 
and deficits in both linear growth and immunogenicity to polio vaccine (62).  These 
findings echoed results of a study in Bangladesh which reported significant associations 
between inflammatory biomarkers of EE, linear growth, and rotavirus and poliovirus 
vaccine failure (63).  Authors estimated nearly half of the change in height-for-age and a 
quarter of the variation in rotavirus vaccine-induced plasma IgA were explained by 
selected biomarkers. 
These data support the hypothesis that enteric pressure in early life drives changes in 
gut function, which in turn act on nutritional outcomes and propel the cycle of 
undernutrition and infection.   Nonetheless, there remains doubt as to whether enough is 
known to intervene; despite mounting evidence and critical evaluation by expert 
committees, precise case definitions and optimal biomarkers are still lacking, and results 
of interventions specifically targeting EE with interventions have been inconsistent at 
best (64,65).  
Intestinal microbiota and the gut microbiome. 
The human intestinal tract is host to a dense and diverse community of microbes whose 
genetic make-up is collectively termed the gut microbiome (66).  This community is 
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predominantly comprised of bacteria, known as the microbiota, but also includes viruses, 
fungi and archaea (67). Millions of years of co-evolution have resulted in complex 
interplay between the structure and function of the human gut and the microbiota residing 
therein (68). Recently, advances in genetic sequencing techniques have provided the 
scientific community with tools to study host-microbe relationships in greater detail.  The 
following section will briefly summarize key research pertaining to the putative role of 
the gut microbial community in enteropathy and growth in early life. 
Variation in human gut microbiota. The gut microbial community is comprised of 
at least 100 trillion microbial cells which can be characterized as either symbionts 
essential and beneficial to the host, or pathobionts, which are commensal in a healthy 
host but opportunistically pathogenic (69).  Studies have revealed the existence of an 
identifiable core microbiome, with community structures and functional gene profiles 
exhibiting congruity across different populations (70–72).  However, presence and 
abundance of specific bacterial taxa vary within and more extensively between 
individuals (73–75). Understanding and describing how microbial populations vary 
across age, geography, and phenotypic traits and developing appropriate metrics for 
identifying ‘healthy’ or ‘high risk’ profiles have been a focus of the emerging research.  
The human gut is anatomically formed during gestation, where it remains largely 
devoid of microbiota; during and after birth, acquisition of gut bacteria occurs in stepwise 
phases according to various early life events (69,76,77).  Method of birth, for example, 
determines whether the gut environment is initially influenced by maternal fecal and 
vaginal (vaginal delivery) or skin flora (caesarian section) and is associated with changes 
to the timing and progression of colonization (78–80). A wide body of literature also 
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illustrates dietary factors as key determinants of this ecosystem, with breastfeeding 
driving dominance of taxa that metabolize human milk oligosaccharides in early life, and 
subsequent weaning and exposure to complementary foods as key events triggering a 
further stage of diversification and proliferation of the gut microbial community 
(69,75,78,81–84).  Thereafter, the gut is thought to progress towards an “adult-like” state 
marked by more stability and resilience, with enduring inter-individual heterogeneities 
but a markedly reduced variation within the individual (75,76,85–87).  
Literature describing variation in microbial profiles may use species-level metrics, 
such as the presence or relative abundance of particular taxa, as a descriptor of the gut 
community at different life stages.  The ecologic principle of species diversity or 
richness, which predicts that more diverse communities have increased resilience to 
interruption or invasion, has also been employed to judge the ‘health’ of the microbial 
community.  In microbiome research, shifts in relative abundance of different groups or 
loss of species diversity is frequently referred to as ‘dysbiosis,’ and is hypothesized to 
confer deleterious health outcomes (69,85,88–90).  However, no clear case definitions or 
cutoffs for dysbiotic phenotypes are agreed upon in the literature, and the term is often 
used to describe the presence or absence of microbial populations inconsistently 
depending on the outcome being measured or the population being studied.  Judging the 
‘health’ of the microbial community in early life, during a highly plastic stage marked by 
sensitivity to external events, presents additional methodological challenges; volatility of 
bacterial populations during this time does not necessarily denote ill health, but instead 
may be following a healthy progression to an adult-like state.  The stepwise manner of 
this progression in early life, coupled with observations that dysbiosis of adult microbiota 
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can cause it to resemble the infant microbial community, implies that there exists some 
optimal rate or pattern of bacterial assembly that occurs in humans as they transition from 
a sterile fetal gut environment to a stable, ‘healthy’ mature profile (85).  This has led to 
the development of a ‘maturity’ metric, which compares the gut community in a given 
sample to that which would be expected of a healthy child at that same age, as a tool for 
assessing whether the gut microbial community is implicated in compromised health 
growth and health of young children in LMIC (66,91). A more complete discussion of the 
methodology underlying these indicators is provided in the methods section of this 
document.   
 
Contribution to health.  The gut microbial community operates synergistically with the 
human host to fulfill key metabolic and immunological functions, and is therefore 
implicated in a wide range of health outcomes. Microflora ferment dietary components 
that are otherwise indigestible to the human host, producing short-chain fatty acids that 
can be absorbed by the gut and thereby promoting dietary energy harvest (92–94). 
Metabolic functions of microbiota also include synthesis of amino acids and vitamins K, 
B12, and folic acid, and absorption of magnesium, calcium and iron (92,94,95). Transfer 
of bacteria from over- or under-nourished humans can induce obesity and undernutrition 
in germ-free mice.  That these conditions develop holding diet constant, and can be 
manipulated and reversed using different microbial populations, further suggests a causal 
relationship between gut microbiota and differential energy harvest, weight gain, and 
growth (91,96–99).  
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Studies in vitro and in animal models have also revealed profound impacts of gut 
microbiota on the mechanical, immunological and mucosal layers of the intestinal barrier.  
Substrates of microbial metabolism in the gut contribute to T-lymphocyte differentiation, 
antimicrobial peptide release from plasma cells during infection, development of gut-
associated lymphoid tissues (GALT) and upregulation of tight-junction proteins of the 
gut epithelia (30,93,100–103). Colonization by microbiota immediately after birth is 
thought to prime the naïve gut, triggering development, differentiation and maturation of 
immune cell populations and help to maintain the homeostatic balance between tolerance 
and inflammation (104–106). Encouraging data from murine models point to the impact 
of manipulating microbiota to improve immunogenicity to influenza (107), Salmonella 
(108) and rotavirus (109) vaccines. The apparent role of the microbiota in 
immunomodulation and barrier integrity also provides a plausible linkage to EE, which is 
marked by disruptions to both.  Recent work demonstrated that a particular profile of gut 
microbiota induced the phenotype of environmental enteropathy, defined as increased 
intestinal permeability and inflammation, in mice (110).  
Evidence that interruption to the gut ecosystem has nutritional and immunological 
consequences has also been generated in human populations, largely using observational 
studies. In high-income settings, extensive work has documented differences in microbial 
populations of individuals with obesity (111–113) and type II diabetes (114,115). 
Microbial indices are further implicated in an array of inflammatory and autoimmune 
conditions, with diversity and relative abundance of particular genera differing among 
patients with inflammatory bowel diseases, including Crohn’s disease and ulcerative 
colitis (116,117), asthma (79), food allergies (118) rheumatoid arthritis (119) and 
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colorectal cancer (120,121).  Disruptions to microbiota have also been linked with 
infectious disease risk, with the most convincing causal evidence illustrated by the case 
of Clostridium difficile. Sustained antibiotic use in hospital settings profoundly 
compromises the microbiota, allowing colonization by C. difficile (122).  The ensuing 
symptoms, which range from diarrhea to fatal forms of colitis, can be treated with fetal 
microbiota transplantation to restore the gut microbial ecosystem (123).  In vitro and 
murine studies have also recently demonstrated changes to intestinal microbiota as 
factors in enabling infection, colonization and pathogenesis of diseases of Giardia and 
Campylobacter spp., enteropathogens of significant public health relevance in LMIC 
(124,125).  These particular infections have been cited as illustrative examples of the EE 
hypothesis, due to their contribution to diarrhea as well as asymptomatic enteropathy and 
their associations with long-term developmental sequelae.   Characterization of microbial 
risk factors or consequences of infection with these enteropathogens will be important to 
understanding the role of the microbiota in driving this cycle.  
 These data have largely been generated in ‘developed’ contexts providing insights for 
populations living in environments with a marked lack of exposure to pathogenic and 
nonpathogenic microbes early in life (126).  Equivalent work on relationships between 
the microbiome, immunomodulation, and disease risk in areas further upstream in the 
epidemiologic transition, those in which the cycle of enteropathogens pressure and 
undernutrition is most dramatic, is comparatively lacking.    
Microbiota and child growth and immunity in LMIC.  Studies among young children 
in LMIC do suggest that significant differences exist in the microbiota according to 
nutritional profiles. This evidence is strongest when severe, acute undernutrition, or low 
 17 
weight-for-length, is the key exposure or outcome. Reductions in global diversity and the 
overall number of OTU, and differences in presence and abundances of numerous taxa, 
have been observed to correlate with weight-for-length profiles in Bangladesh, Malawi, 
Niger and Senegal (66,97,127,128). Children with severe and moderate acute 
malnutrition were also found to have significantly reduced microbial maturity; while this 
improved during nutritional therapy, gains were transient and declined within 4 months 
of treatment cessation. Taken together, these studies demonstrate that children with acute 
malnutrition appear to have distinct populations and rates of microbial progression in 
early childhood in a manner that may endure even beyond treatment.  Further, the 
induction of wasting in mice upon fecal transplantation from study subjects in Malawi 
and Bangladesh (91,97) convincingly demonstrates that these microbial communities 
impact weight gain. This has led to interest in the development of microbiota-directed 
therapeutic foods and probiotic interventions for the resolution of acute undernutrition 
(128,129); however, the studies detailed remain limited in number and sample size and 
no experimental trials have yet been conducted. Nonetheless, they serve to illustrate the 
biological plausibility that gut microbiota are implicated in the cycle of undernutrition in 
LMIC.   
Fewer studies have considered the relationship between microbiota and chronic 
undernutrition, which drives a greater proportion of long-term disability worldwide. 
Community-level, taxonomic and functional alterations to the microbiota have been 
observed among children with linear growth shortfalls in India, Malawi and Bangladesh. 
However, none interrogate the pathway of linear growth failure in a specific manner; 
instead, all enroll children based on a composite malnutrition score inclusive of other 
 18 
phenotypes like low birth weight or ponderal growth failure, or conduct retrospective 
analyses of children initially enrolled in studies of wasting (130–132). Studies designed 
to measure this relationship in a more specific manner, and among more representative 
samples of young children, are needed to elucidate the potential role of the gut microbial 
community in driving chronic undernutrition in LMIC.  
Studies assessing gut microbial impacts on enteric immunity and disease in this 
demographic have also emerged in the literature.  Recent work suggests that diarrhea can 
have lasting impacts on the bacterial communities in the gut, citing differences in 
taxonomic composition, diversity and maturity during and after illness (66,133–135) in 
young children in LMIC.  Few human studies have been conducted to replicate findings 
that microbiota impact the ability to launch effective immune responses, though this has 
been suggested by the observation of heightened response to oral Salmonella typhi 
(Ty21a) vaccine (136) as well as systemic E. coli and Salmonella infections (137). 
Investigators have further explored this question by measuring impacts of probiotics on 
immunogenicity and vaccine efficacy, with disparate and often disappointing results 
(138).  This may be due to the lack of consistency of the type, dose and duration of pre- 
and probiotic treatment; the age, ethnicity, and socioeconomic and geographic profiles of 
participants; and the kinds of vaccines studied.  Evidence assessing the potential interplay 
between microbiota and features of EE such as asymptomatic infection, inflammation and 
intestinal permeability are even more scarce.  To our knowledge, there is no published 
work specifically assessed the role of asymptomatic enteric infections on the gut 
microbial community, and only one recent study conducted in Malawian children found 
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significant differences in presence and abundance of particular taxa among children with 
severe EE (139).  
While this evolving body of work provides a compelling case for the possible role of 
the microbiota in driving the interactions between undernutrition and enteric infection 
and disease, there exists a clear need to elucidate potential mechanisms further and build 
an evidence base that is inclusive of broader populations of children in LMIC. Recently, 
experts in the field of childhood undernutrition have called for the specific interrogation 
of pathways through which infection may alter the microbial environment, and a more 
comprehensive description of associations between gut microbial environment and 
features of EE, as research priorities for achieving global targets in the reduction of 
childhood stunting worldwide (140).  The following section distills these theories into a 
theoretical framework and outlines the specific aims of this dissertation. 
Theoretical framework & specific aims 
Figure 1 depicts the described relationships between enteric infection and illness, 
undernutrition, and compromised immunity and illustrates ways in which they may be 
driven by microbiota in the gut and EE.  The current dissertation was conceived to assess 
these relationships in the Santa Clara Cohort, a birth cohort of 303 children enrolled at 
one site (Peru) of the multi-country cohort study entitled ‘The Interactions of 
Malnutrition & Enteric Infections: Consequences for Child Health and Development 
(MAL-ED).’   The first component of this work aims to describe relationships between 
anthropometric and microbial indices in the first two years of life, the most critical 
postnatal window for growth acquisition and nutritional intervention. Subsequent 
analyses were designed to detect possible impacts of diarrheal disease and asymptomatic 
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infections on the gut microbial community, which has been highlighted as an important 
research objective in the effort to elucidate how intestinal infections and subsequent 
illness illicit long-term disabilities via growth and immunological impairments 
throughout life.  
 
Figure 2: Theoretical framework illustrating possible role of the gut microbiota in driving the cycle 
between enteric infections and undernutrition in LMIC 
 
Theories were summarized using data from the studies summarized in the previous section with citations listed at the 
end of this chapter. Pathways investigated in the specific aims of this dissertation are shown in red.  
 
Specific aims.   Specific aims of this research were designed to interrogate relationships 
between the gut microbial community, metrics of growth acquisition, and symptomatic 
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and asymptomatic enteric infections in early life (pathways shown in red above).  We 
sought to first replicate findings described elsewhere that children with different growth 
profiles also have detectable differences in their gut microbial community (Aim 1).  We 
then measured whether alterations in the gut community are associated with increased 
incidence of all-cause diarrhea, and in turn whether diarrhea has lasting impacts on the 
gut community (Aim 2).  Finally, we sought to link these questions to the theory of EE, 
by partitioning analyses into symptomatic and asymptomatic carriage of a single 
enteropathogen and chronicling whether and how these exposures may impact microbial 
species composition in the gut (Aim 3).  Campylobacter spp infections were selected for 
this analysis due to their high prevalence in this population and their observed impacts on 
child growth and other long-term disabilities, both in this cohort and elsewhere.  The 
underlying hypothesis of these analyses was that gut microbial indices would both reflect 
ponderal and linear growth disparities among children in this community, and be 
detectably altered by frequency or intensity of both symptomatic and asymptomatic 
enteric insults.  Specific aims are listed below: 
Aim 1: Detect and describe associations between gut microbial metrics at 6, 12, 18 and 
24m and growth acquisition in the Santa Clara cohort 
1a): Assess whether gut microbial maturity (MAZ) is indicative of ponderal 
(WLZ) and linear (LAZ) growth deficits from birth to two years of age 
1b): Assess whether measures of gut microbial diversity and richness differ 
among children with linear growth faltering from birth to two years of age 
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Aim 2: Detect and describe bi-directional associations between diarrheal disease and 
microbial diversity and richness, and assess whether associations endure over time 
among children age 0-24m in the Santa Clara cohort 
2a) Measure impacts of diarrheal frequency, duration and severity on subsequent 
metrics of microbial diversity and richness in the infant gut 
2b) Measure associations between measures of gut microbial and richness and 
subsequent diarrheal incidence from birth to two years of age 
2c) Measure whether and how detected associations differ by stunting status, 
weaning status, and time 
Aim 3: Evaluate associations between Campylobacter infection, community and species-
level of gut microbial metrics, and child growth among children 0-24m of age in the 
Santa Clara Cohort 
3a) Assess impacts of symptomatic and asymptomatic Campylobacter infections 
on measures of gut microbial diversity and richness 
3b) Identify whether particular gut microbial members are associated with 
Campylobacter infections among children in the Santa Clara cohort, and assess 
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Chapter 3: Study Context & Methodology 
The current study is nested within the MAL-ED Study, a collaboration between the 
National Institute of Health, the Fogarty International Center, the Bill & Melinda Gates 
Foundation, and a broad network of biomedical research institutions and eminent 
investigators at the forefront of research in child health, nutrition, environmental and 
specifically enteric disease, and cognitive development (1–11). The MAL-ED Study is a 
longitudinal birth cohort of children from 0-60 months of age in eight countries who 
continue to suffer the consequences of the cycle between poverty, undernutrition, 
enteropathy, and compromised immunity.  Communities in each of the eight participating 
countries were selected and followed according to a unified protocol to provide a more 
complete description of the inter-relationships between enteropathy, growth, immunity, 
and cognitive development and inform intervention design for children living in poverty. 
Detailed descriptions of MAL-ED protocol and methods have been published and are 
referenced throughout the subsequent chapters (1–4,8,10,12,13); however, the following 
section provides a brief description of the data collection and diagnostic methodology 
employed in the parent study.   
Sample selection & enrollment 
Fieldworkers performed a community census to enumerate populations of women of 
reproductive age.  Catchment areas were then identified with an aim of recruiting at least 
200 children per site.  Healthy infants were enrolled within 17 days of birth and followed 
longitudinally until 24 months between November 2009 and February 2012. All sites 
received ethical approval and informed consent.  Inclusion and exclusion criteria for the 
MAL-ED Study are listed in Box 1.  
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Box 4: Criteria for enrollment in the MAL-ED Study across eight sites (8) 
Inclusion Criteria 
 Healthy infant enrolled within 17 days of birth 
 Caregiver report that they had no plans to move out of catchment area for at 
least 6 months following enrollment 
 Willingness to be visited in the home twice weekly  
 
Exclusion Criteria 
 Reported plans to move out of catchment area for a period of >30 days within 
6 months of proposed enrollment date 
 Maternal age < 16 years 
 Sibling enrolled in MAL-ED study 
 Child was not a singleton 
 Indications of serious disease: 
o Hospitalization for atypical birth  
o Severe or chronic condition diagnosed by medical doctor 
o Enteropathies diagnosed by medical doctor 
 Guardian did not provide consent 
 Weight at birth or enrollment <1500g 
 
The current work is nested within one site, MAL-ED Peru, in Santa Clara de Nanay. 
MAL-ED Peru: Santa Clara de Nanay 
Peru is an upper middle-income country of 30.4 million people in South America 
with a vastly diverse geography and ethnic composition. While it is among the fastest 
growing economies in Latin America, with a gross domestic product of over $202 billion 
(14), populations living in urban slums and remote coastal, mountainous or Amazonian 
regions are persistently characterized by poor socioeconomic, health and nutritional 
indices (14). The Department of Loreto, located in the lowlands of the Amazonian jungle, 
is one such region.   
Loreto is geographically Peru’s largest region, with international borders with 
Ecuador, Colombia, and Brazil.  According to a 2012 national census by the National 
Institute of Statistics and Informatics, Loreto is home to 1.1 million inhabitants, nearly 
half of whom (457,900) are based in the departmental capital of Iquitos.   
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This Amazonian region experiences consistent rain throughout the year, with an 
annual peak in January during which flooding is common.  The average annual 
precipitation is 3.4 meters and the average temperature is 25.8° C/78.4° F.   Seasonal and 
annual variations in precipitation and climate are important factors determining the 
economic and nutritional profiles of these communities, who often rely on fishing, 
logging and farming for subsistence and livelihood.  Loreto region consistently 
demonstrates some of the poorest health and economic indices in the country (11).  
Access to water, sanitation, and livable wages is markedly lower than elsewhere in Peru, 
and the burden of infectious disease remains high.  Infant and child mortality are both 
considerably higher than the national average (see Table 1).    
Table 2: Health indicators comparing Peru, Loreto region, and the MAL-ED Cohort, adapted from 
(11) 
Indicator Peru Loreto MAL-ED 
Cohort 
    
Access to health services    
  Clean water (% of households) 72.5 23.8 NA 
  Improved sanitation  (% of households) 58.4 27.1 20.2 
  Receive all vaccinations (% of children) 71.0 53.9 NA 
  Delivering in facility (% of women) 85.1 53.1 81.3 
  Receive postnatal care (% of women) 69.9 40.9 NA 
    
Health outcomes    
Life expectancy  (years) 72.5 69.9 NA 
Children born underweight (% born under 2.5 kg) 6.5 9.1 10.6 
Proportion of U5 stunted (%) 19.5 31.0 46.3 
Proportion of U5 wasted (%) 0.4 1.9 0.2 
Proportion of U5 underweight (%) 0.5 8.9 5.6 
Proportion of U5 with reported diarrhea in past 7 days 13.9 30.4 35.4 
Under 5 Mortality Rate (per 1000 live births) 21.0 60.6 NA 
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The MAL-ED team in Peru is based out of Santa Clara de Nanay, a research facility 
situated approximately 15km southeast of Iquitos.  This site covers participants from 
three rural communities, Santa Clara, Santo Tomas and La Union, located along the 
Nanay River.  The approximately 5000 families in these communities are estimated to be 
demographically representative of the population in Loreto region (11).  A collaboration 
between the Johns Hopkins Bloomberg School of Public Health, the Asociation Benefica 
PRISMA and the United States Naval Medical Research Unit No. 6 has been operating 
and conducting research from this site for over a dozen years.  A total of 303 children 
were enrolled for inclusion in MAL-ED at the Santa Clara de Nanay fieldsite, with an 
expected high loss to follow-up due to frequent seasonal displacement and an aim to 
retain a minimum of 200 children in the study.   
Data collection 
Measurement of demographic and nutritional covariates.  At enrollment, date of birth, 
sex, birth weight, length, weight, head circumference, and details on breastfeeding 
initiation were recorded.  Ongoing information on diet and breastfeeding was collected 
during surveillance visits monthly in the first year of life and quarterly in the second and 
is described in detail elsewhere (10).  A complete list of dietary exposure variables and 







Box 5: Dietary exposures collected in MAL-ED (10) 
  
Dietary recall questionnaires started at 9 months of age 
 
Stool collection and microbiology. Routine stool collection was conducted monthly, with 
additional samples collected during diarrheal episodes occurring in between planned 
routine visits.  Diarrhea was defined as ≥3 loose stools in a 24-hour period and separated 
by at least two diarrhea-free days. Children experiencing moderate to severe diarrhea 
were referred to local health services. Caregivers were enlisted to collect fresh stool and 
specimens were collected and transported to the laboratory for processing monthly on the 
day of their birthday or upon occurrence of diarrhea.  A depiction of enteropathogens 
assays is shown in Figure 1, with detailed description of bacterial culture methods, 
immunoassays for protozoa and viruses, and microscopy harmonized across all eight sites 
described elsewhere (12). 
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Figure 1: Microbiologic methods for enteropathogen identification in MAL-ED (12) 
 
 
Surveillance. A surveillance system was designed for all MAL-ED sites to quantify 
common exposures and disease states that may be associated with growth and 
development in early life (13).  Active surveillance was conducted to provide daily illness 
and treatment history for children and identify diarrheal episodes for specimen collection.  
Illness and treatment history was collected twice-weekly by fieldstaff. Visits were made 
every 3-4 days to ask mothers or caregivers whether children experienced symptoms or 
were treated with any medications featured in Box 3.  Answers to these questions were 
then used to assign illness categories based on pre-specified case definitions for common 
childhood illness, such as acute lower respiratory infections and diarrhea.  In cases of 
missed surveillance visits, recall was ascertained for no more than 7 days prior.  All data 
collection materials were translated into Spanish, and verbal questionnaires were also 
conducted by fieldstaff from the region in their native language.   
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Box 6: Questions featured in illness and treatment history questionnaire, administered twice-weekly 
in MAL-ED (13) 
 
Quality control 
A technical subcommittee within MAL-ED was established to produce standard 
operating procedures, checklists and questionnaires and provide guidelines and uphold 
minimum quality standards across all MAL-ED sites (13). Field supervisors reviewed all 
forms prior to entry and conducted surveillance on 10% of households monthly for 
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quality control purposes.  The percent agreement at the Peru site was above 90% for 
classification of any illness, diarrhea, fever and antibiotic use.  A central Data 
Coordinating Center was also assembled for additional quality control screening for all 
sites (13).  
Ethical considerations 
All participants provided written informed consent as a prerequisite to inclusion in the 
study.  Consent forms were read to parents and/or guardians.   A copy of a consent form 
was left in the family’s possession. This study received ethical approval from the Johns 
Hopkins Institutional Review Board as well as from the partner organization, Asociation 
Benefica PRISMA, in Iquitos, Peru. 
The Peru Microbiota Collaboration 
The Peru Microbiota Collaboration was launched in 2015 with the Gordon Laboratory at 
Washington University in St Louis, one of the foremost institutions leading innovations 
in genome science and technology in the world, to link the epidemiologic data generated 
by The Iquitos Satellite Laboratory (IQTLAB), the institution responsible for research at 
the Peru site of the MAL-ED Consortium, to indicators of gut bacterial composition and 
functioning. Led by Dr. Jeffrey Gordon, a pioneer in establishing the role of the gut 
microbiota in human health and promoting translational research for the development of 
clinical interventions, this institution is a leader in publishing novel methodologies in 
microbial and metagenomic analyses and linking derived indices to issues of public 
health importance (15–24). In August 2017, the Gordon Laboratory completed bacterial 
and genomic analysis of over 1000 fecal samples from 303 children in the Peru cohort, 
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comprising the largest longitudinal database of gut microbial indices from infants living 
in LMIC to our knowledge. 
Enrollment/inclusion 
All 303 children were eligible for inclusion in the study, irrespective of subsequent loss 
to follow up. Two inclusion processes were executed: the first, to select a sub-cohort of 
children exhibiting ‘healthy’ growth to serve as a reference population for the generation 
of microbial maturity metrics; and the second, to select from stools contributed by the full 
population within which to conduct analyses for aims 1-3 of this work.   
Selection of the subsample of children with unperturbed growth was conducted as 
follows:  children were eligible for inclusion if their weight-for-length and length-for-age 
Z-scores, denoting wasting and stunting histories respectively, were never detected to be 
below -1.5 standard deviations below 0 between birth and their 2nd birthday.  Twenty-two 
children met these criteria.  Monthly routine stools for these participants were then sent to 
the Gordon Laboratory for to comprise a reference population for subsequent comparison 
of age-discriminatory taxa (described below). 
All children in the cohort (n=303) were eligible for inclusion in the study.  For each 
child, we selected the routine stool sample available at 6, 12, 18 and 24m of age.  Where 
this sample was missing, we selected the surveillance stool collected 1m preceding or 
following the optimal age, with preference for whichever was collected the shortest 
amount of time from their 6, 12, 18 or 24th month dates.  This produced a sample of 271 
children at baseline, and 200 children at endline.  
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Processing of stool samples for microbial analysis  
DNA was isolated from aliquots of pulverized, frozen fecal samples. Fecal samples 
were homogenized by bead beating for 4 minutes (MiniBeadbeater-96TM, Biospec 
Products; Bartlesville, Oklahoma USA) in a mixture of 250 μL of 0.1 mm-diameter 
zirconia/silica beads (and a 3.97 mm-diameter steel ball for a subset of samples), 710 μL 
of 500:210 2X buffer A (200 mM NaCl, 200 mM Tris, 20 mM EDTA):20%SDS, and 500 
μL of 25:24:1 phenol:chloroform:isoamyl alcohol, pH-adjusted to alkaline. Samples were 
then centrifuged at 3,220 x g for 4 min at room temperature.  350 uL of aqueous phase 
was transferred to a new tube containing 500 uL 25:24:1 phenol:chloroform:isoamyl 
alcohol, pH-adjusted to alkaline. The tubes were inverted 10 times to mix and then 
centrifuged at 3220g X 4 min. 250 uL of aqueous phase was transferred to a 96-well 
plate. DNA was purified from a 100 uL aliquot of each 250 uL crude DNA sample by 
mixing 100 uL of crude DNA with 400 uL of a 675:45 mix of Qiagen® buffer PM:3M 
NaOAc, pH5.5 and then passing the mixture through a Qiagen® QIAquick96  plate by 
centrifugation at 3220g X at least 4 min. Wells were washed twice by passing 900 uL 
Qiagen® buffer PE through the plate by centrifugation at 3220g X at least 2 min. Quant-
iT dsDNA Broad-Range Assay Kits (Invitrogen; Carlsbad, California, USA) was used to 
quantify the pure DNA. 
For each DNA sample, the V4 regions of bacterial 16S rRNA (V4-16S rRNA) genes 
present were amplified using previously published primers (25) and the following PCR 
conditions: an initial denaturation step of 2 min at 94°C, followed by 26 cycles of 15 sec 
at 94°C, 30 sec at 50°C, and 30 sec at 68°C, followed by a final step at 68°C for 2 min. 
Amplicons were sequenced using an Illumina MiSeq instrument. The resulting 250-
nucleotide paired-end reads were trimmed to 200 bases and merged with Flash, and 
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QIIME (v 1.9.0) (26) was used to demultiplex the reads and cluster them into operational 
taxonomic units (OTU; clusters sharing ≥97% sequence identity). OTU that failed 
alignment by PyNast (27) were removed from the dataset. Taxonomy was assigned to 
each OTU using the Ribosomal Database Project (RDP) classifier version 2.4 (28) and 
the 2013 Greengenes reference database (29). The resulting OTU table contained 
32,300±16,453 (mean±sd) reads per sample. Subsequently, OTU that did not have 
relative abundances of ≥1% in at least one sample or ≥0.1% of the reads in at least two 
samples were removed from the data. The data were then rarefied to 11,000 reads per 
sample, and Shannon’s diversity index, the total phylogenetic diversity, and the observed 
number of OTU for each community were calculated as measures of microbial richness 
and diversity. Samples that did not have at least 11,000 reads were removed from the 
data. 
Generation of outcomes of bacterial diversity & maturity 
Bacterial diversity and richness. Alpha diversity metrics are commonly employed in 
community ecology to describe the variation in species composition within a given 
sample within a given community.  Diversity metrics account for richness, the number of 
overall species present in a sample, and the abundance of each.  Four metrics of species 
richness and diversity were utilized in this study, described below.  
Shannon diversity index (SDI). The Shannon Diversity Index (SDI) accounts for the 
number of species (richness) and their distribution (evenness) to capture diversity within 
samples.  SDI describes the amount of information in a given sample using the sum and 
proportional abundance of each particular OTU, with equal sensitivity to rare and 
abundant species (30).  Higher SDI values denote greater species richness and evenness; 
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a maximum value for this metric is therefore reached when all species within a given 
sample are perfectly evenly spread. The formula for this metric is shown below, where pi 
is the proportion of species i relative to all species in a given sample.   
 
CHAO1 Estimator. The CHAO1 estimator of species richness is a nonparametric method 
that calculates the total number of species in a given sample as a function of the number 
of species observed, and the probability that they are observed more than once in the 
same sample (31,32).  This method is adapted from the mark-recapture-release statistics 
employed for counting animal populations (33,34), and assumes that the probability of 
observing the same species more than once is greater in a sample with lower diversity. 
The formula for the CHAO1 estimator is shown below, where Sobs is the total number of 
species observed; n1 is the number of species observed once; n2 is the number of species 
observed twice (re-captured):  
 
Faith’s Phylogenetic Diversity (PD).  The PD metric estimates richness in an ecological 
community by calculating the sum of the branch lengths of phylogenies within a given 
sample (35).  This measure does not account for abundance of species, but incorporates 
the degree of divergence between species in its assessment of richness:  two taxa closely 
related will together contribute less to the overall metric, by virtue of their shared 
phylogenetic material, than two taxa that are highly divergent.  
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Simpson’s diversity. Simpson’s diversity index (36) estimates the probability that 
randomly selected species within a sample, selected with replacement, will be different.  
This metric is calculated as the sum of the proportional abundances of all OTU within a 
given sample, and is bound by 0 and 1 as it represents a probability. The Simpson index 
is weighted towards more dominant species, which are more likely to be sampled at 
random.   
 
Microbial maturity. Maturity measures have specifically been developed to describe the 
possible differences in development and maturation of the infant gut microbiome that 
may be implicated in differential growth and nutritional uptake during a critical postnatal 
period (25).  Identification of microbial taxa that characterize children exhibiting healthy 
growth at different chronological ages provides a template against which to compare 
other individuals (25).  Metrics derived from age-discriminatory characteristics of the gut 
environment are referred to as indicators of microbial maturity.   
Microbiota-for-age Z scores (MAZ). To generate microbial maturity metrics, the relative 
abundance of each OTU was regressed against the age of the child using a Random 
Forests Machine Learning Algorithm (RF).  The RF technique is a statistical procedure 
identifying distinct groups of a population whose members share a common association 
with the predictor of interest; in this case, the procedure identifies the predominant 
groups of taxa associated with each age bracket (month of life).  Evaluation of high-
throughput sequencing techniques for characterization of the human microbiome cites RF 
as among the most accurate classification methods for microbiome data, judged on ability 
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to correctly classify groups and produce minimal levels of uncertainty in modeling their 
association with descriptors of interest (37).   
Age-discriminatory taxa derived using RF were ranked at each age group in order of 
their contribution to model accuracy. Species were ordered based on the degree to which 
their rank permutation increased uncertainty in the predictive accuracy of the model, as 
measured by the mean-squared error. This procedure was first conducted among 50 
healthy infants in Bangladesh, and the derived model was applied to other healthy 
populations to determine its ability to predict age-discriminatory taxa in different 
populations.  Application to two other groups within Bangladesh (13 healthy singletons 
and 25 healthy twins and triplets) supported the consistency of the ‘signature’ of OTU at 
each age (25).  The model was also found to generalize to a cohort of 47 twins and 
triplets exhibiting healthy growth in Malawi (25), demonstrating predictive accuracy 
across geographic locales and environmental pressures.  Further cross-validation has 
recently been conducted with an aggregated sample of 27 children from Peru, Brazil, 
India and South Africa.  These data support the use of this model to accurately predict the 
presence of key microbial taxa in the healthy infant gut across populations; most 
encouragingly, when the Bangladesh model was applied to a dataset of 507 samples from 
22 children with healthy growth included in our analysis, it demonstrated strong 
predictive accuracy (r2=0.76; Ahmed, Huq & Subramanian, unpublished).   
The ‘microbiota age’ of a fecal sample, therefore, is the age corresponding to the 
signature of taxa in that sample.  Among healthy children, this corresponds to the 
chronological age of the child; but among children exhibiting different growth 
trajectories, the microbiota age may not be aligned with what is expected for a healthy 
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child of the same chronologic age.  The microbial maturity metric is then calculated as a 
standardized Z-score as follows (25): 
Microbiota-for-age Z-score=  
(microbiota age- median microbiota age of healthy child of same chronological age) 
(standard deviation of microbiota age of healthy children of that chronological age) 
Analytic approach  
The advantage of the study design of MAL-ED and other longitudinal cohorts is the 
ability to measure both risk factors and outcomes as they change over time, providing 
more valid estimates of exposures and allowing temporality of cause and effect to be 
monitored. The current study employs both cross-sectional and longitudinal statistical 
methods to characterize relationships between predictors and outcomes throughout the 
first two years of life.  
One distinctive feature of longitudinal data is the clustering of observations within 
each individual.  Repeat measurements over time violate the critical assumption of 
independence between observations; it is likely that metrics measured within the same 
individual will be more correlated with one another than with observations from other 
individuals.   Thus, there is a vector of responses for each individual, with the adapted 
assumption that each response vector is independent; in other words, the vector of 
microbial outcomes measured within one child does not depend on those measured within 
another. A single value is used to represent exposures that do not vary over time, like 
gender or baseline characteristics, and a vector of covariates is generated for time-varying 
exposures like infection status.  The covariance of responses and exposures within 
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individuals must be statistically accounted for in order to avoid incorrect inferences based 
on measures of precision calculated under the assumption of independence.   
The current study employs a generalized estimating equations (GEE) approach 
(38,39) as a statistical strategy to adjust for within-child clustering.  This approach 
models the mean response across the population while accounting for clustering of 
responses within individuals over time. An important strength of this approach is that it 
requires few assumptions about the characteristics of the covariance of correlated 
observations, allowing for valid inference without making distributional assumptions.  
This is a strong justification for its use with our outcome data; due to the unstable nature 
of microbial measures in early life when the gut is very plastic (40) and the relatively 
novel metrics being used, fewer assumptions about how measurements relate to one 
another over time may inform more valid models.  In addition, while greatly detailed 
characterization of microbial markers over time has been conducted in the form of 
within-person panel studies, population-level epidemiologic studies remain absent.  Thus, 
we employ GEE to estimate population-averaged trends in microbial indices according to 
enteric exposures among children over the first two years of life.  
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Chapter 4: Childhood undernutrition and patterns of microbial 
maturity, diversity and richness in the developing infant gut: results of a 
24-month longitudinal cohort in Peru 
 
ABSTRACT.  
Background. The global burden of undernutrition underlies nearly half of all under-five 
mortality and drives considerable loss of human potential among children living in 
poverty. Interventions to promote growth have been disappointing, calling for novel 
approaches to understand and target pathways implicated in growth faltering. Recent 
evidence suggests there may be casual relationships between the gut microbiota and child 
growth, but representative studies are needed to provide a more complete description of 
these relationships at the population level. We describe associations between gut 
microbial maturity, diversity and linear and ponderal growth acquisition in a birth cohort 
of 271 children aged 0-24m in Peru. 
Methods.  Routine fecal samples collected at 6, 12, 18 and 24m of age (n=928) were 
used to identify gut bacterial taxa with polymerase chain reaction (PCR) primers 
detecting 16S ribosomal RNA, and resulting data was used to generate metrics of gut 
microbial maturity (microbiota-for-age Z-score; MAZ), diversity and richness (Shannon, 
Simpson, CHAO1 and phylogenetic diversity). Monthly anthropometric measurements 
were used to calculate length-for-age (LAZ) and weight-for-length (WLZ) Z-scores. 
Longitudinal associations between gut microbial metrics and patterns of linear and 
ponderal growth were assessed using a generalized estimating equations approach to 
adjust for within-child clustering and produce population-averaged effect estimates. We 
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conducted sub-analyses restricted to children born stunted and those severely stunted. 
Analyses were adjusted for diarrhea, infection, breastfeeding, dietary diversity and 
antibiotic exposure. 
Results. Two-thirds of children (67%) were stunted, while only 9% of children 
experienced wasting. Children with lower LAZ had higher WLZ on average (β=-0.24, 
p<0.001). Measures of gut microbial diversity and richness increased significantly with 
age and weaning, and were suppressed by breastmilk exposure. We detected a suggestive 
relationship between microbial maturity and WLZ one month thereafter (β=0.03, 
p=0.071) after adjustment for breastfeeding. We did not observe evidence of associations 
between microbial maturity, diversity or richness with LAZ in the full cohort. However, 
MAZ was positively associated with LAZ among the children who were wasted (β=0.55, 
p=0.004), and LAZ at birth was significantly associated with MAZ score throughout 
follow-up (β=0.10, p=0.012). Children born stunted had significantly lower gut microbial 
diversity and richness (Shannonβ=-0.19, CHAO1 =-9.75; p-values <0.05) from birth to 
two years of age, and there was significant evidence that faltering of diversity acquisition 
trajectories among these children was exacerbated by cessation of breastfeeding before 
24m of age.  
Conclusions. We present data describing trends in microbial maturity, diversity and 
richness, and describe their associations with child growth in one of the largest cohorts to 
profile these relationships to date. Findings support the hypothesis that gut microbial 
maturity is related to weight gain among young infants in lower and middle-income 
countries. We detect deficits in gut microbial diversity and richness among children born 
stunted, and demonstrate evidence that these deficits endure two years after birth and are 
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greater among children who are weaned before their 2nd birthday. This provides impetus 
for programs to emphasize messaging around continued breastfeeding as an important 
component for nutritional and intestinal health.  
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INTRODUCTION.  
The global burden of undernutrition underlies nearly half of all under-five mortality 
(1). Stunting, a condition denoting linear growth failure or low length-for-age, continues 
to affect over 160 million children worldwide (1,2). In contrast with ponderal growth 
deficits resulting from acute malnutrition, stunting results from chronic nutritional 
insufficiency, with intergenerational consequences compounding long-term health and 
socioeconomic inequities worldwide (3). Furthermore, while acute undernutrition carries 
with it a higher relative risk of mortality, a far greater proportion of children suffer from 
chronic undernutrition and its consequences (1). Despite the clear evidence of its 
detriments to the survival and development of vulnerable children, understanding of the 
full spectrum of mechanisms driving linear growth failure remains incomplete and 
interventions to prevent stunting have largely failed (4). Strategies to address this gap 
range from expanding equitable access and uptake of evidence-based programs, to 
investment in novel genomic and basic science research to elucidate precise pathways 
that may inform innovative intervention targets.  
Given the growing body of evidence implicating intestinal microbes in human health 
and nutrition, there is increasing interest in whether gut microbial composition, or the 
composite functional metabolic profile of the microbial community may help to 
understand linear growth failure in populations living in poverty.  The intestinal 
microbial community has been shown to regulate metabolism and digestion by 
fermenting and harvesting dietary components, and transfer of bacteria from over- or 
under-nourished humans can induce obesity and undernutrition in germ-free mice (5–9). 
While human studies demonstrating the importance of gut flora in nutritional conditions 
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such as obesity and type II diabetes (10–14) are more abundant, evidence in lower- and 
middle- income countries (LMIC) implicating intestinal flora in undernutrition are only 
now emerging.  
Studies conducted in Malawi and Bangladesh comparing healthy children to those 
with acute malnutrition, or low weight-for-length, have suggested that there are 
differences in presence and abundance of specific phyla and reductions in overall 
bacterial diversity among children with severe acute malnutrition (SAM) (5,15–17). 
Three studies to our knowledge have considered the relationship between linear growth 
and microbial indices. One study conducted in 20 rural Indian children classified 
undernutrition by constructing a composite score representing both linear and ponderal 
shortfalls, and found community-level, taxonomic and functional differences were 
associated with the overall condition of malnutrition in this group of children examined at 
a single point in time (18). Specific indicators of linear growth deficits were not 
investigated. A second study conducted a retrospective case-control analysis using data 
from Malawi and Bangladesh children whose microbiota were initially assessed for 
associations with SAM (19). In a comparison of cases and controls from both countries, 
investigators noted reduced diversity and increased abundance of Acidaminococcus 
among children with lower height-for-age. Finally, a third recent study compared 10 
cases of children with low birth weight and persistent stunting and documented 
episode(s) of diarrhea in the first 24 months of life to healthy controls, who had a normal 
birth weight, were not stunted nor had diarrheal disease at any follow-up measure in the 
first 24 months of life. Authors reported increased relative abundance of Bacteroidetes 
and enriched communities of inflammogenic taxa among cases (20). While these studies 
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inform hypotheses that fecal microbiota may be implicated in linear growth failure, all 
were conducted in very small samples of children with co-occurring nutritional deficits. 
Further work is needed to produce more generalizable results, and to specifically 
interrogate putative pathways between microbiota and stunting.  
That the critical period for linear growth faltering occurs before two years of age 
presents important methodological challenges to assessing the role of the microbial 
community in child undernutrition. Even among adults whose microbial communities 
have long been established, the scientific community has yet to reach a consensus on 
what comprises a ‘healthy’ gut population. The post-natal period is the time when a naïve 
neonatal gut is first exposed to the environment outside of the womb; judging the 
microbial health of a developing and rapidly diversifying infant gut therefore poses 
additional challenges to defining a favorable pattern and rate of microbial assembly. To 
address this constraint, a novel metric called the microbial maturity Z-score (MAZ) was 
recently developed to assess whether gut populations among undernourished children 
diverge from an expected pattern of assembly at each month of life from 0-24m, relative 
to children exhibiting healthy linear and ponderal growth in children living in LMIC (21). 
Validation of this measure across cohorts of children living in Bangladesh, Malawi and 
Peru suggests that despite variations in the microbiota, there may be a conserved pattern 
of acquisition of a set of taxa associated with healthy growth during of this critical 
postnatal period. When this metric was tested in Bangladesh and Malawi, it was found 
that microbial maturity was significantly increased among healthy children relative to 
those with severe or moderate acute malnutrition, with some evidence pointing to the 
recovery of MAZ scores during nutritional therapy (5,17). This novel metric may 
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therefore be a useful tool for understanding healthy microbial development among 
vulnerable children, but it has yet to be assessed as an appropriate indicator of linear 
growth at the population level.  
Studies to date have largely comprised translational projects with observational data 
from very small sample sizes of children selected according to extreme nutritional 
phenotypes that are then in turn used to inform experimental murine models. 
Epidemiologic studies powered to assess potential population-level associations between 
appropriate indicators of gut microbial health and nutritional indices are needed to 
understand whether this promising new field of research may help to address the burden 
of childhood stunting. We sought to detect and describe possible associations between 
child growth and microbial maturity and diversity through 24m of life in a well-
characterized large longitudinal birth cohort of infants living with high burden of chronic 
undernutrition in the Peruvian Amazon. Specifically, we assess whether previously 
observed associations between MAZ and ponderal growth were detectable in this setting, 
and whether MAZ and microbial diversity are associated with linear growth.  
 
METHODS.  
Study setting. This nested study was conducted in collaboration with the Etiology, Risk 
Factors, and Interactions of Enteric Infection and Malnutrition and the Consequences for 
Child Health and Development (MAL-ED) Study, a multi-site longitudinal cohort based 
in eight settings characterized by high childhood undernutrition and diarrhea. Data was 
retrieved from one participating MAL-ED site based in Santa Clara de Nanay, a peri-
urban riverine community in Loreto province of the Peruvian Amazon. Heavy periods of 
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rain and flooding impact food stability as well as water and sanitation access and quality 
in this region. Rates of chronic undernutrition are considerably higher than elsewhere in 
Peru, though acute malnutrition is relatively uncommon. An extensive description of this 
site has been published (22).  
Study design. A high rate of loss to follow-up was anticipated due to frequent travel 
along the river, resulting in proposed enrollment of 300 children with an aim to retain a 
birth cohort of at least 200 for the MAL-ED Study. Children were enrolled within 17 
days of birth and followed to two years of age between November 2009 and February 
2012. Date of birth, sex, birth weight, anthropometrics and details on breastfeeding 
initiation were recorded at enrollment. To describe patterns of asymptomatic infections 
and enteric disease, routine stool collection was conducted monthly and additional stool 
samples collected during each diarrheal episode throughout follow-up. Active 
surveillance was conducted twice-weekly to provide illness, treatment, breastfeeding 
practices and dietary intake history, and weight and length were measured monthly to 
generate calculate anthropometric measures of growth attainment. Details of data 
collection for MAL-ED are available elsewhere (23–26). Fecal specimens from routine 
collections at 6, 12, 18 and 24m of age were frozen at -70° C and selected for 16S rDNA 
profiling.  
Specimen analysis. Analysis of routine and diarrheal fecal specimens was conducted 
according to a unified MAL-ED protocol designed to detect the presence of over 40 
enteropathogens. Details of microscopy, bacterial culture methods, immunoassays and 
amplification methods to identify bacteria, protozoa and viruses across all eight sites have 
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been published (27). Diagnostic analysis generating infection and illness history was 
conducted at AB Prisma in Loreto, Peru.  
Analysis of the gut microbiota from the subsample of 928 stools selected at quarterly 
intervals was conducted at the Gordon Laboratory at Washington University in St. Louis, 
Missouri. DNA was isolated from aliquots of pulverized, frozen fecal samples. Fecal 
samples were homogenized by bead beating for 4 minutes (MiniBeadbeater-96TM, 
Biospec Products; Bartlesville, Oklahoma USA) in a mixture of 250 μL of 0.1 mm-
diameter zirconia/silica beads (and a 3.97 mm-diameter steel ball for a subset of 
samples), 710 μL of 500:210 2X buffer A (200 mM NaCl, 200 mM Tris, 20 mM 
EDTA):20%SDS, and 500 μL of 25:24:1 phenol:chloroform:isoamyl alcohol, pH-
adjusted to alkaline. Samples were then centrifuged at 3,220 x g for 4 min at room 
temperature.  350 uL of aqueous phase was transferred to a new tube containing 500 uL 
25:24:1 phenol:chloroform:isoamyl alcohol, pH-adjusted to alkaline. The tubes were 
inverted 10 times to mix and then centrifuged at 3220g X 4 min. 250 uL of aqueous phase 
was transferred to a 96-well plate. DNA was purified from a 100 uL aliquot of each 250 
uL crude DNA sample by mixing 100 uL of crude DNA with 400 uL of a 675:45 mix of 
Qiagen® buffer PM:3M NaOAc, pH5.5 and then passing the mixture through a Qiagen® 
QIAquick96  plate by centrifugation at 3220g X at least 4 min. Wells were washed twice 
by passing 900 uL Qiagen® buffer PE through the plate by centrifugation at 3220g X at 
least 2 min. Quant-iT dsDNA Broad-Range Assay Kits (Invitrogen; Carlsbad, California, 
USA) was used to quantify the pure DNA. 
For each DNA sample, the V4 regions of bacterial 16S rRNA (V4-16S rRNA) genes 
present were amplified using previously published primers (17) and the following PCR 
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conditions: an initial denaturation step of 2 min at 94°C, followed by 26 cycles of 15 sec 
at 94°C, 30 sec at 50°C, and 30 sec at 68°C, followed by a final step at 68°C for 2 min. 
Amplicons were sequenced using an Illumina MiSeq instrument. The resulting 250-
nucleotide paired-end reads were trimmed to 200 bases and merged with Flash, and 
QIIME (v 1.9.0) (28) was used to demultiplex the reads and cluster them into operational 
taxonomic units (OTU; clusters sharing ≥97% sequence identity). OTU that failed 
alignment by PyNast (29) were removed from the dataset. Taxonomy was assigned to 
each OTU using the Ribosomal Database Project (RDP) classifier version 2.4 (30) and 
the 2013 Greengenes reference database (31). The resulting OTU table contained 
32,300±16,453 (mean±sd) reads per sample. Subsequently, OTU that did not have 
relative abundances of ≥1% in at least one sample or ≥0.1% of the reads in at least two 
samples were removed from the data. The data were then rarefied to 11,000 reads per 
sample, and Shannon’s diversity index, the total phylogenetic diversity, and the observed 
number of OTU for each community were calculated as measures of microbial richness 
and diversity. Samples that did not have at least 11,000 reads were removed from the 
data. 
To characterize the relative maturity of the gut microbiota, we additionally assessed 
monthly fecal samples from 22 children in the cohort whose anthropometric data never 
fell below -1.75 standard deviations from the reference mean. A random forests machine 
learning algorithm was used to predict the ages of each sample from the 22 healthy 
reference children, taken up to 2 years of age, from the rarefied OTU relative 
abundances. Feature importance scores were assigned to each OTU using the difference 
in the mean-squared error of the model when the OTU was included or excluded. One 
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hundred independent runs of the algorithm were performed, and 30 OTU with the 
greatest mean feature importance scores across all runs were retained to create sparse 
models. Subsequently, 1,000 unique, randomly selected training sets of 11 of the 22 
healthy reference children were generated, and a separate random forests model 
predicting the ages of samples from these training sets, including only the 30 selected 
OTU in the sparse set, was generated for each set. Thirty OTU were selected for the 
sparse random forests model to maintain consistency with similar sparse models 
constructed for other sites, using the criterion that the number of OTU included should 
have a mean squared error within 1% of that of optimal number of OTU across 100 
implementations of 10-fold cross-validation. Using each model, the age of each sample 
from all children not in the training set was predicted. For each sample, the mean 
predicted age across all these models was used as its predicted age. The median and 
standard deviation of these predicted ages was calculated for each 1-month age bin, and 
each sample’s microbiota-for-age z-score (MAZ) was calculated as the ratio of the 
difference between that sample’s predicted age and the median for the appropriate age 
bin and the standard deviation for that age bin. 
Analytic approach.  
Definition of covariates and outcomes. Standardized weight-for-length (WLZ) and 
length-for-age (LAZ) Z-scores were calculated according to the World Health 
Organization’s Multicentre Growth Reference Study Group guidelines from 2016 (32). 
Cutoffs of -2 standard deviations were used to classify children as wasted (WLZ) or 
stunted (LAZ) at each time point under follow-up. Children were classified as severely 
stunted at or below -3 LAZ. Covariates considered for inclusion in modeling 
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relationships between child growth and gut microbial indices included diarrhea, 
asymptomatic infection with a known enteropathogen, antibiotic use and infant feeding 
practices. Diarrheal episodes were defined as occurrence of ≥3 loose stools in a 24-hour 
period, and asymptomatic enteropathogen exposure was measured by calculating the 
mean number of pathogens detected in surveillance stools contributed per child at each 
follow-up measure. Breastfeeding was measured using a first categorical metric to 
indicate whether children were exposed to breastmilk only (exclusive), mixed milk and 
other liquids (predominant) or foods (partial), or weaned. Intensity of exposure to 
breastmilk was also quantified by using the maternal report of number of reported feeds 
in the past 24 hours to calculate a cumulative, moving average of the number of feeds per 
child throughout follow-up. Dietary diversity was defined as the cumulative number of 
seven complementary food groups children had ever been exposed to by each follow-up 
measure (33). Antibiotic exposure was considered as a continuous variable enumerating 
the number of days with reported antibiotic exposure per child.  
  The standardized MAZ score was used to denote microbial maturity at each quarter of 
life. The primary measure of diversity used in this analysis was the Shannon Diversity 
Index (SDI), a measure of within-sample bacterial diversity accounting for number and 
distribution of different species with equal sensitivity to rare and abundant species (34). 
Secondary outcomes included the CHAO1 (35), which uses a capture-recapture method 
to enumerate species richness; phylogenetic diversity (36), calculated as the sum of all 
phylogenetic branch lengths represented within a sample; and Simpson’s Diversity (37), 
the sum of the squared frequency of all OTU within a sample. 
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Statistical analyses. Longitudinal data analyses were conducted to describe patterns of 
linear and ponderal growth from birth to two years of age, and sequence plots were 
employed to visualize transitions between categories based on age normalized (Z-score) 
categories for LAZ per individual throughout follow-up. Longitudinal associations 
between linear and ponderal growth and between anthropometrics and microbial indices 
were assessed using multiple linear regression with a generalized estimating equations 
approach to adjust for within-child correlation across the monthly or quarterly time points 
depending on the outcome. Cumulative measures of time-varying covariates were 
calculated at 6, 12, 18 and 24 months of age for adjustment in final models of microbial 
maturity, diversity and richness. Associations between anthropometrics and the 
microbiota were assessed separately at each quarter of life using generalized linear 
models specifying continuous outcomes. Models were additionally adjusted for LAZ at 
birth, breastfeeding and complementary feeding exposures, infection and diarrhea history 
and antibiotic exposure, which were included as a priori confounders depending on the 
relationship being tested. Models assessing relationships between MAZ and growth were 
adjusted for breastfeeding exposure, weaning status and anthropometric measure at birth; 
dietary, illness and treatment variables were excluded from preliminary analyses due to 
the novelty of this metric and the lack of evidence as to how these factors may affect the 
particular age-discriminatory OTU comprising the MAZ score. However, due to clear age 
trends and a wider body of evidence linking additional covariates to microbial diversity, 
dietary diversity, diarrhea, infection and antibiotic history, and age were additionally 
included in fully adjusted models assessing relationships between diversity, richness and 
child growth.  
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RESULTS. 
Description of the population. Two-hundred and seventy-one of the 303 MAL-ED 
children (89.4%) were included in the Peru Microbiota Collaboration; the remaining 32 
children who were not included were lost to follow-up prior to 6m of age. Monthly 
measurements for 146 boys and 125 girls were used for generation of infection, illness 
and anthropometric history from 0-24 months. Throughout 6096 months of person-time 
under follow-up, children contributed 6,011 surveillance stools and 2,440 diarrheal 
samples to the study. Mean number of anthropometric visits per child was 22.1 from birth 
to two years of age.  
Stool samples at 6, 12,18 and 24m of age were selected for microbial sequencing and 
generation of maturity and diversity indices. The 271 children contributed a total of 928 
samples to this analysis (mean 3.4 samples per child). Throughout follow-up, 93% (250), 
85% (231), and 79% (213) of children remained under follow-up at 12, 18 and 24m of 
age respectively.  
Child growth in the Santa Clara cohort. Overall, 181 (66.7%) of the 271 children 
included in the collaboration were stunted (LAZ<-2) at least once from 0-24m of age. 
Approximately one in five children (22.1%) in the cohort were severely stunted (LAZ<-
3) at least once throughout follow-up. Thirty-four children (12.6%) were stunted at 
enrollment, which occurred within 17 days of birth, and an additional 90 fell below -
2LAZ at least once before 6m of age. While 40% of the 213 remaining under follow-up 
at 24m of age were stunted, 70% had measured below -2LAZ at one or more of their 
monthly anthropometric visits (see Table 1). Transitions between categories of stunting 
severity are shown in Figure 1. We found that children who were stunted at least once 
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before two years of age measured at below -2LAZ on 45% of their visits on average. The 
majority of children did remain consistent in binary stunting status throughout the first 
two years of life: the probability that a child would be classified as not stunted, given 
they were not stunted at the last quarterly measure, was 79%; the probability that a child 
who was stunted six months prior remained stunted at a given visit was 76%.  
While 25 children were wasted (WLZ<-2) on at least one occasion before 2 years of 
age, mean Z scores in this cohort were higher than the WHO reference for healthy 
weight-for-length at each quarter of life. Over half of all children were recorded to have 
WLZ above +2SD at least once before their second birthday. In a model adjusting for 
age, LAZ at birth, breastfeeding frequency, weaning status, infection and diarrheal 
history, there was an inverse correlation between WLZ and LAZ scores in this 
population; children with lower LAZ had higher WLZ, on average (aβ=-0.24, p<0.001). 
Figure 2a shows linear and ponderal growth trajectories by age; Figure 2b shows the 
difference in linear growth trajectory stratified by wasting. An interaction term was added 
to explore whether LAZ trajectories differed significantly between children above and 
below -2WLZ, and this was found to be statistically significant (p<0.001). After 
stratification by wasting status, children above -2WLZ decreased in LAZ score at a rate 
of 0.02SD per month of life (p<0.001) after adjustment for covariates. In contrast, 
children who were wasted decreased in LAZ score by 0.07SD per month of life 
(p=0.001).  
Microbial indices in the Santa Clara Cohort. Mean maturity, diversity and richness 
indices at each quarter of life are shown in Table 2. All diversity indices increased 
significantly by month of age, but this association was not seen for the age-standardized 
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MAZ score (β=-0.01, p=0.119), as expected. Breastfeeding frequency, calculated as mean 
number of feeds in last 24 hours, had a significant suppressive effect on all microbial 
indices, and weaning was significantly associated with increased indices throughout 
follow-up (p<0.001). After adjustment for age and weaning, cumulative dietary diversity 
score was positively associated with all microbial indices. Associations between 
microbial indices, age, breastfeeding and dietary varirelativeables are shown in Table 3.  
Associations between microbial maturity and growth. No significant association was 
detected between MAZ and WLZ throughout life (β=-0.05, p=0.118), and this did not 
change after adjustment for breastfeeding or weaning status (aβ=-0.02, p=0.458) nor 
when modeled separately at each time point. Mean MAZ scores were lower among stools 
contributed by wasted children relative to non-wasted children; however, there were only 
10 children (15 specimens) meeting these criteria who contributed specimens to the 928 
samples in Peru Microbiota Collaboration (Table 4). When we investigated whether 
MAZ at 6, 12, and 18m of age were predictive of subsequent WLZ scores 1m and 6m 
thereafter, we found that MAZ was significantly predictive of increased WLZ score 1m 
but not 6m thereafter. In a model adjusting for WLZ score at current time point, a 1-point 
increase in current MAZ score was associated with a mean increase of 0.03 WLZ one 
month thereafter (β=0.03, p=0.035). When breastfeeding frequency and weaning status 
were accounted for, the effect size was unchanged but the threshold for statistical 
significance was no longer met (aβ=0.03, p=0.071).  
No significant relationship between MAZ and LAZ was observed in the cohort 
throughout the first two years of life in univariate or adjusted model (β=0.02, p=0.305; 
aβ=0.03, p=0.156). Given the distinct LAZ trajectory shown among wasted children in 
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Figure 2b, we investigated whether the relationship between MAZ and LAZ also differed 
within this subpopulation. Holding age constant, MAZ was found to be positively 
associated with LAZ among the 10 children (15 observations) who were wasted at the 
time of quarterly follow-up measures, (β=0.55, p=0.004). After additional adjustment for 
LAZ at birth, breastfeeding frequency and weaning status, each 1-point increase in MAZ 
score among wasted children was associated with a mean increase of 0.40LAZ (p=0.013) 
from 0-24m of age. Finally, we observed that length at birth was significantly associated 
with lifetime MAZ score (β=0.10, p=0.012); a 1-point increase in LAZ score at birth was 
associated with a mean increase of 0.11 in MAZ score from birth to 24 after adjustment 
for breastfeeding frequency, weaning status and diarrhea history (aβ=0.11, p=0.008; 
Table 5). 
Associations between microbial diversity and linear growth in the Peru cohort. We 
observed a negative association between LAZ score and diversity indices in unadjusted 
analyses including age as the only covariate, but this was not significant after adjustment 
for LAZ at birth, breastfeeding and dietary behaviors, and diarrhea and infection history 
(Shannon: aβ=-0.03, p=0.174; CHAO1: aβ=0.00, p=0.474; PD: aβ=-0.01, p=0.300; 
Simpson: aβ= -0.19, p=0.118). However, we did find significant evidence that LAZ at 
birth impacted microbial diversity from birth to two years of age, shown in Table 5. In 
fully adjusted models, children who were born stunted had reduced lifetime microbial 
diversity and richness as measured by three of the four metrics assessed. Only eight of the 
34 children in the cohort who were born stunted recovered by 24m of age; while this 
study was not powered to detect significant differences within this subgroup, we did 
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observe lower diversity metrics among those 26 children who were unable to recover 
growth (defined as attainment of LAZ>-2 by 24m), relative to those who were.  
Given the expected changes in diversity over this period of life, we sought to measure 
specifically whether diversity acquisition was compromised between children of different 
growth profiles (Figure 3). The apparent increase in diversity seen among those 25 
children who were severely stunted, but not born stunted, was explained by the increased 
proportion of weaned children in this group: 60% were weaned by two years of age, 
relative to only 27% of the all other children. After adjustment for weaning, there was no 
significant relationship between severe stunting and diversity acquisition among children 
who were not born stunted in this cohort. However, children who were born stunted did 
experience significantly reduced diversity acquisition in the second year of life, after 
adjustment for covariates (Table 6).  
Our observation that breastmilk exposure appears to suppress microbial diversity 
(Table 3) led us to test the a posteriori hypothesis that children diverge in their diversity 
trajectories when exposure to breastmilk ceases. We found significant evidence of 
interaction by weaning, supporting this hypothesis. In the presence of breastmilk, there 
was no significant reduction in diversity among those children born stunted; however, 
once weaned, these children exhibited reduced diversity and richness relative to those 
born at above -2LAZ (Table 6).  
 
DISCUSSION.  
This work serves to support the growing field of evidence highlighting differences in 
gut microbial profiles of children with disparate growth trajectories living in lower and 
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middle-income settings. We describe associations between microbial diversity and 
maturity with ponderal and linear growth in the largest sample to our knowledge in which 
these relationships have been interrogated. In contrast to previous work in Bangladesh 
and Malawi (5,17), we do not report the MAZ metric as a significant indicator of wasting 
in this population. However while patterns of ponderal growth in this cohort were 
comparable to other Latin American settings, they are extremely dissimilar to contexts in 
which MAZ has been used before. Children in the Santa Clara cohort were born 
considerably above the standard weight for their height, and the prevalence of wasting 
was very low relative to South Asian or African settings (1,38). We also observed a lower 
variability in MAZ than expected, with the population mean close to zero for all time 
points except 18 months when maturity exhibited a dip before recovering by two years of 
age. Therefore, we caution against the interpretation of these findings as a refutation of 
the utility of the MAZ marker. Due to the distributions in WLZ and MAZ observed, this 
population may not be an appropriate one with which to draw inferences about the 
relationship between microbiome maturity metric and child wasting. Given that we did 
note a trend in reduced MAZ among the very small number of children contributing 
samples while wasted, our finding may be a reflection of sample size. Our observation of 
significant interaction between wasting and stunting is consistent with the literature 
(38,39).  Further, that we observe pronounced linear deficits among children with any 
wasting history, in conjunction with the detection of a significant relationship between 
LAZ and MAZ among these children only, lends evidence to the possibility of an 
underlying relationship between WLZ and MAZ. We did not detect any relationship 
between linear growth metrics and microbial maturity in the wider cohort, and to our 
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knowledge, no other studies have assessed potential relationships between MAZ and 
linear growth.  
We describe patterns of diversity acquisition in 271 children living in an area of 
endemic diarrhea and enteropathy and demonstrate significant dietary determinants of 
this trajectory over 24 months. The presence of breastmilk in infants’ diets appears to 
exert a suppressive effect on all four markers of diversity and richness, while weaning 
and increasing exposure to a greater number of WHO-defined food groups are correlated 
with increased diversity and richness metrics thereafter. Our findings are consistent with 
the wider literature demonstrating the resilience to external events, such as antibiotic 
challenge and food introduction, that characterize the gut microbiota of breastfed infants, 
and the subsequent expansion of diversity with exposure to complementary foods (40–
48). These observations have led to an evolving hypothesis that healthy infant gut 
progression is marked by limited diversity in early life (49). Breastmilk selects for the 
high abundance of only taxa that can metabolize human milk oligosaccharides, most 
notably Bifidobacteria, thus leading to low overall diversity. Authors of a recent review 
suggest that low diversity driven by the presence of breastmilk is therefore not 
detrimental, but if the gut community does not diversify after cessation of breastfeeding, 
it may confer health risks (49). While evidence is largely derived from high-income 
settings, low microbial diversity in early life has been linked to asthma, allergy and Type 
I diabetes (50–56), and its association in adulthood with a range of inflammatory, 
immune, and infectious disease risk has been extensively reviewed (57–60). Laursen et 
al. call for longitudinal studies specifically employing repeat measures of microbial 
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diversity and dietary intake to further elucidate the rate and timing of microbial 
progression in the infant gut.  
The current study meets these criteria and produces findings consistent with their 
hypothesis; we detect little variation in microbial outcomes while breastfed, but when 
exposure to breastmilk ceases we observe rapid diversity acquisition and children begin 
to diverge in their trajectories. Indeed, we note reduced diversity acquisition among 
children in one nutritionally vulnerable group: those born at least two standard deviations 
beneath the standard reference (or born stunted). Specifically, we report that children 
born stunted experience a distinct pattern of microbial acquisition that is pronounced in 
the second year of life and after weaning, which results in significantly lower values of 
diversity and richness than those born above -2 LAZ. Furthermore, we observed higher 
diversity among children in this subgroup who were able to recover growth and measure 
above -2 LAZ by two years of age relative to those who remained stunted. While this 
comparison was done among very few children and was not statistically significant, it 
further supports the hypothesis that failure to diversify the gut environment beyond the 
period of breastfeeding denotes vulnerabilities.  
Thirteen percent of children in our cohort were stunted at birth, and that LAZ at birth 
was a significant predictor of subsequent growth. That stunting often begins in utero and 
has lasting impacts on growth is well documented, and the target period for nutritional 
interventions has expanded accordingly to prioritize the 1000 days from conception to 
two years and extend to women of childbearing age (1,61,62). However, research 
assessing the gut microbiota of children born with prenatal growth faltering is sparse. 
One exception is the case of necrotizing enterocolitis (NEC), a potentially fatal condition 
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characterized by intestinal pneumotosis, which has been linked to altered gut microbiota 
among babies born pre-term. Studies in high-income countries have indicated reduced 
diversity as a correlate of NEC, and recent systematic analyses indicate that probiotics 
prevent clinical progression and death (63,64). Of the three studies evaluating microbial 
differences according to linear growth faltering in LMIC settings, one case-control of 20 
children included low birth weight babies (20). While they did not find statistically 
significant differences in diversity they noted increased relative abundance of 
Lactobacilli and Bifidobacteria in controls, and of Bacteroidetes and inflammogenic taxa 
in cases. We present evidence that prenatal linear growth faltering is associated with 
distinct gut microbial metrics enduring over a year beyond birth, and that this apparent 
compromise is significantly more impactful in weaned children. Our ability to understand 
how these deficits arise is limited by the absence of maternal variables in this study. 
Maternal nutritional indices as well as fecal, vaginal and breastmilk samples for 
microbial sampling would allow us to characterize potential differences in the flora to 
which children of undernourished mothers are exposed, and may help to further elucidate 
microbial pathways through which intergenerational stunting occurs. Nonetheless, this 
data adds a novel element to the evidence of health risks conferred by intrauterine growth 
restriction, and further supports public health efforts to target nutritional interventions 
before birth. Specifically, our results suggest that continued breastfeeding may be 
important to offset potential intestinal risks of being born at low length for age. 
Continuing breastfeeding to two years receives less emphasis than exclusive 
breastfeeding in global health messaging, as evidenced by its omission in the World 
Health Assembly’s 2025 nutrition targets (65), and has recently been noted to decline 
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among the poorest populations (66,67). This work, in the context of the growing body of 
evidence revealing the importance of breastfeeding duration and not just exclusivity (68), 
should inform nutrition behavior change campaigns to prioritize the promotion of 
continued as well as exclusive breastfeeding in the first 6 months of life.  
We did not identify any significant patterns of gut microbial diversity among children 
who were born above -2 LAZ and then became stunted later in life. Studies that have 
assessed and found associations between microbial diversity and linear growth metrics 
have relied on case control design with quite extreme phenotypes. Furthermore, they do 
not discriminate between children born stunted and those who later became stunted. That 
we did not find any microbial markers of postnatal linear growth failure in our cohort 
may be due to several reasons. First, we did not investigate beta-diversity, nor relative 
abundances of bacterial taxa, both of which have been reported to differ according to 
linear growth in the existing evidence. It is possible that alpha-diversity is unaffected 
among children who become stunted, but key species responsible for nutrient harvest or 
metabolic or inflammatory responses exhibit distinct progression. Second, this population 
was characterized by a high toll of chronic undernutrition, as evidenced by the mean LAZ 
at two years of age at the threshold of stunting. Reassessing these relationships in a less 
skewed population with a broader spectrum of healthy growth trajectories may be more 
appropriate for detecting differences between groups. Other limitations of this work 
include our reliance on 16S rRNA gene sequencing to identify bacterial taxa in the gut. 
While this methodology has been standard in the literature, its limitations are well 
documented, including limited precision in identifying bacteria at the species level and 
risk of bias towards amplifying genes from particular groups over others (69–71). Whole-
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genome sequencing should be employed for future studies in order to improve precision 
as well as expand analyses to characterizing metabolomic and proteomic functions of 
microbial populations in the human gut, which have been shown to be more preserved 
across geographic settings than bacterial populations (72).  
The current study echoes much of the existing literature surrounding linear growth 
failure, in that it illustrates another mechanism through which prenatal events can set 
children on a path to growth failure but fails to identify any tangible patterns among 
children who become stunted after birth. This highlights an ongoing challenge in the 
field; while stunting that occurs prenatally is still not fully understood, estimates suggest 
that approximately 80% of the burden occurs in children who are not born with signs of 
intrauterine growth restriction (61,62). Therefore, while the focus on nutrition 
interventions for women of childbearing age is of irrefutable importance to promoting 
child health and development in LMIC, the research community has yet to identify clear 
markers and intervention targets to address the vast burden of children suffering from 
stunting without any signs of predisposition at birth. Additional analyses interrogating 
various characteristics of the gut microbiota that may differ among children with 
postnatal linear growth failure in multisite cohort studies, such as the one in which the 
current work was nested, will be invaluable to understanding whether there are actionable 
targets in the gut microbial community that can help alleviate the worldwide burden of 
stunting. Nonetheless, this work represents the first large scale birth cohort to 
longitudinally assess microbial acquisition trajectories during a critical window for child 
growth and development, and provides evidence that children with intrauterine growth 
restrictions resulting in short length at birth experience compromised gut diversity that 
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not only endures but is magnified two full years thereafter. More work is needed to 
confirm and further describe which bacterial populations are most affected, and inform 
possible interventions such as pre- or probiotic supplementation for children born with 
existing nutritional vulnerabilities. 
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Table 1: Anthropometric indices demonstrate low prevalence of wasting but progressive linear 
growth failure among children in the Peru Microbiota Collaboration  
Mean anthropometric indices at each quarter of life from 0-24m among 271 children in the Peruvian 
Amazon 
 Age (months) 
Anthropometric indicators  
[mean (sd); 95%CI] 























     
Stunting Indicators %(n)     
Proportion stunted at each 
age (LAZ ≤-2) 
22.2 (60) 31.5 (78) 42.9 (96) 40.1 (87) 
Proportion ever stunted by 
each age 
45.9 (124) 56.1 (139) 69.2 (155) 70.1 (151) 
Proportion stunted at last 
visit who are stunted at this 
visit 
80.0 (48) 78.2 (61) 94.8 (91) 93.1 (81) 
Proportion severely stunted 
at each age (LAZ≤-3) 
4.1 (11) 5.3 (13) 10.3 (23) 10.8 (23) 
Proportion ever severely 
stunted by each age 
13.3 (36) 17.3 (17) 23.2 (52) 24.4 (52) 
     
Wasting Indicators % (n)     
Proportion wasted at each 
age 
0 (0) 1.6 (4) 2.7 (6) 1.4 (3) 
Proportion ever wasted at 
each age 











Table 2: Limited variation in microbial maturity and progressive attainment of diversity and 
richness among children in the Peru Microbiota Collaboration 
Mean metrics of microbial maturity, diversity and richness in surveillance stools at each quarter of life 
among 271 children in the Peruvian Amazon 
 Age (months) 
 6 12 18 24 
Microbiota maturity  
[mean (sd); 95%CI] 
    









[mean (sd); 95%CI] 
    










































Table 3: Breastmilk exposure is significantly associated with reduced microbial diversity, richness and maturity, which increase in conjunction 
with weaning and increasing dietary diversity 
Associations between breastfeeding, weaning, dietary exposure and microbial indices from 0-24m of age among 271 children in the Peruvian Amazon.  
 Metrics of gut microbial maturity & diversity 
Mean (SD); 95%CI 
 MAZ Shannon CHAO1 Phylogenet
ic Diversity 
Simpson 



























































*Estimates are age-adjusted for diversity indices but not for MAZ. 






Table 4: Children with wasting show delayed microbial maturation in the Peru Microbiota 
Collaboration.  
Mean MAZ in 15 samples contributed by children while wasted (n=10), relative to 913 samples contributed 
among non-wasted children (n=271). 
 MAZ 
Mean (SD); 95%CI 
Age Wasted  Non-wasted 
6 NA 0.19 (0.11) 
-0.03, 0.40 





























Table 5: Significant reductions in microbial diversity and richness associated with low length-for-age 
at birth 
Results of multivariable linear regression testing associations between length at birth and microbial 
maturity, diversity and richness from 0-2 years of age among 271 children in the Peru Microbiota 
Collaboration. 
 Metrics of gut microbial maturity & diversity 
Mean (SD); 95%CI 
 MAZ Shannon CHAO1 Phylogeneti
c Diversity 
Simpson 




























   Recovered 
(n=8) 
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MAZ estimates adjusted for breastfeeding frequency and weaning; diversity estimates additionally adjusted 















Table 6: Pronounced reductions in gut diversity and richness in the second year of life and by 
weaning status among children born stunted  
Results of multivariable linear regression models testing for interactions between being born stunted and i) 
year of life or ii) weaning status in the relationship between being born stunted and gut microbial diversity 
among 271 children in the Peru Microbiota Collaboration  
 Metrics of microbial diversity & richness 
Mean (SD); 95%CI 
 Shannon CHAO1 Phylogenetic 
Diversity 
Simpson 








Year of life       
Year 1 (0-12m) Ref    








Interaction term  
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Models are adjusted for age, breastfeeding frequency, dietary diversity, diarrhea and infection history; 
year of life additionally included as a potential confounder in model assessing evidence for interaction by 








Figure 1: High consistency in stunting classification throughout first two years of life in the Peru 
Microbiota Collaboration 
Sequence plot of 271 children showing changes between stunting categories from 0-24m 
 
Each child represented as a different row on the Y-axis; white denotes loss to follow-up. 
 
 
Figure 2: Trends in linear and ponderal growth from birth to two years of age in the Peru 
Microbiota Collaboration 
Figure 2a: Low length for age and high weight for length at baseline, with steady reductions from 0-24m 
Figure 2b: Pronounced linear growth deficits among children who are wasted  
 










Figure 3: Reduced diversity and richness acquisition among children born stunted relative to other 
growth profiles 
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Chapter 5: Diarrhea as a cause and consequence of reduced gut 
microbial diversity in children in Peru 
 
ABSTRACT.  
Background. Detrimental effects of diarrhea on child growth and survival are well-
documented in vulnerable populations, but mechanisms remain poorly understood. 
Recent evidence demonstrates that gut microbiota influence infection and growth in early 
life, but most has been generated in high-income settings or with small sample sizes. We 
assessed the bi-directional associations between diarrhea and bacterial diversity among 
infants of differing growth profiles from a longitudinal birth cohort with high burden of 
undernutrition and diarrheal disease in Peru.  
Methods. Infection and illness history were ascertained through active surveillance and 
monthly fecal collection from 271 children 0-24m of age. Fecal samples (n=928) at 
quarterly intervals were selected for identification of fecal microbiota using polymerase 
chain reaction (PCR) primers detecting 16S ribosomal RNA and generation of indices of 
diversity and richness (Shannon, Simpson, CHAO1 and phylogenetic diversity). Bi-
directional associations between diarrhea and gut diversity were investigated using 
multiple linear regression with adjustment for within-child correlations, age, 
breastfeeding, infection and antibiotic history, and dietary diversity. We conducted 
secondary analyses to test whether possible impacts of diarrhea on the microbiota 
differed based on stunting or weaning status in the full cohort, or endured beyond one 
month in a subset of children without recent diarrhea or antibiotic exposure (n=71).  
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Results. By two years of age, 96% of children experienced diarrhea. Odds of being 
severely stunted increased by 8% with each additional diarrheal episode throughout the 
first two years of life (OR=1.08; p<0.001). Cumulative diarrheal frequency, duration and 
severity were associated with significant reductions in microbial indices (p<0.05), some 
of which were still detectable beyond one month. We found significant interaction 
between stunting status and diarrheal exposure: children who were born stunted 
experienced greater diversity insults per diarrheal episode than those children who were 
not stunted (Interaction: Shannon β =-0.04, p=0.037; Simpson β =-0.01, p=0.032). Time 
elapsed since last diarrheal exposure was associated with recovery of Shannon (β =0.02, 
p=0.03) and phylogenetic diversity (β =0.11, p<0.01) and we detected evidence that this 
regeneration process was significantly slower among severely stunted children. Lower 
diversity was associated with subsequent diarrheal incidence, with a 1-unit increase in the 
Shannon and Simpson’s Diversity scales at 6m corresponding to a mean reduction of 1.3 
and 3.4 diarrheal episodes from 6-24m of age, respectively. 
 Conclusions. In a population experiencing the classical cycle of diarrhea and 
undernutrition we report evidence that disruptions to the gut bacterial community may be 
implicated in driving the repeated cycle of diarrheal disease experienced by vulnerable 
children during a critical period for growth and development. This is the largest cohort 







The cycle between diarrhea and undernutrition is well described, but remains poorly 
understood. Children in economically disadvantaged settings with a high burden of 
enteric infections and diarrhea experience compromised growth trajectories in early life 
(1), resulting in impaired immunity and increased vulnerability to future illness (2–7). 
These conditions continue to account for a vast proportion of childhood deaths: global 
mortality estimates for children under 5 years of age (U5) attribute 700,000 deaths to 
diarrhea (8), and over 3 million deaths to underlying nutritional deficiencies (9) annually. 
Mortality is not the only consequence; diarrhea is the leading cause of long-term 
disability among children under 5 years of age worldwide due to the consequences of 
repeated disease for cognition and school-performance, intestinal function, child growth 
and overall developmental potential (10–14). New estimates accounting for these 
sequelae increased the number of disability-adjusted life-years lost to diarrhea among U5 
by nearly 40% to over 55 million annually (13), and targeting nutritional shortfalls and 
diarrheal disease have been highlighted as crucial to averting the loss of human potential 
in 200 million children worldwide (15). The persistence of this cycle in the face of 
various child health interventions is therefore troubling (16), and recent research efforts 
have focused on elucidating underlying mechanisms of intestinal health that may be 
crucial to interrupting it.  
Specifically, a growing body of evidence implicates the integrity of gut microbial 
populations in both enteric health and child growth. Gut microbiota are crucial to 
achieving healthy metabolism and digestion as well as modulating host defense against 
pathogens (17,18) and therefore may be implicated in the interplay between infection, 
 90 
immunity and undernutrition in early life. Indeed, a growing body of evidence links the 
gut microbiota to undernutrition. Gut bacterial populations can promote dietary energy 
harvest, amino acid synthesis and micronutrient absorption (19–22), and weight loss can 
be induced by inoculation of germ-free mice with gut flora from undernourished children 
(23). Recent studies have also shown that diversity and composition of the gut microbiota 
differ among undernourished children in lower and middle-income countries (LMIC), 
though most were conducted in children with severe acute malnutrition (SAM) and very 
few have directly assessed relationships between gut flora and linear growth (24–28). 
Studies have also demonstrated changes to particular species and overall gut 
microbial diversity and richness before, during and after diarrhea. These relationships 
have most comprehensively been described in the case of Clostridium difficile 
colonization occurring after antibiotic-driven disruptions to gut flora (29). Consequences 
are severe and can be life-threatening, but may be averted by fecal transplant to restore 
bacterial populations in the gut (30). Comparison of fecal composition between cases and 
controls confirms marked reductions in overall microbial diversity among individuals 
affected, and an observed dose-response in samples from patients with recurrent C. 
difficile suggests that disruptions may be sustained or additive over time (31). A limited 
number of studies have also identified differences in gut bacterial communities among 
adults experiencing travelers’ diarrhea (32) and norovirus infection (33) in the United 
States.  
Less is known about the relationship between diarrhea and the gut microbiota among 
individuals residing in LMIC, especially in young children vulnerable to growth insults 
and other long-term morbidities. One study analyzed fecal samples during and after 
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infection among nine children aged 2-3 years old with confirmed cholera, observing 
reductions in commensal bacteria and an increased prevalence of harmful Proteobacteria 
(34). Another found a significant shortfall in a standardized microbial maturity score 
among children during and up to one month after a diarrheal episode, but not beyond 
(25). While these have been important contributions to evolving hypotheses, they have 
been conducted with very small sample sizes of fewer than 20 children. One notable 
exception is a secondary analysis of 922 fecal samples from the Global Enterics 
Multicenter Study (GEMS) comparing cases of moderate-to-severe diarrhea to controls 
(35), in which investigators report consistently reduced bacterial diversity and distinct 
taxonomic composition in diarrheal stools contributed from birth to 5 years of age (36).  
Among children suffering multiple episodes of diarrhea in early life, microbiota may 
therefore be profoundly affected, perhaps in a manner that could help explain the long-
term consequences of repeated illness in childhood. The case-control and often cross-
sectional design of these studies however limits their ability to detect whether diarrhea-
associated differences in microbial composition and diversity are apparent after 
symptoms subside, and to characterize potential changes to the these metrics over time 
among children experiencing a high burden of disease in early life. To our knowledge no 
study has been conducted in LMIC settings to assess whether children with variable 
diarrheal disease history differ in their microbial succession during this critical window 
for child growth and survival. The current study leverages data from a longitudinal birth 
cohort to explore bi-directional associations between diarrheal disease and microbial 
diversity and richness among 271 children from birth to two years of age living in the 
Peruvian Amazon. We additionally aim to measure whether potential impacts of diarrheal 
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insults on the microbial community endure over time, and whether relationships differ 
according to nutritional indices and complementary feeding practices, in order to 
understand potential interactions between nutrition, diarrheal disease and the developing 




Study setting and design. This study was conducted within the Peru-Microbiota 
collaboration, a partnership between Johns Hopkins University, Washington University 
and Asociación Benéfica PRISMA in Peru. Data was ascertained from the Peru site of the 
Etiology, Risk Factors, and Interactions of Enteric Infection and Malnutrition and the 
Consequences for Child Health and Development (MAL-ED) Study, a longitudinal study 
based in eight settings characterized by high childhood undernutrition and diarrhea (37). 
The research site in Peru is located in the lowlands of the Amazon basin, a region 
consistently demonstrating some of the poorest health and economic indices in the 
country. Access to water, sanitation, and livable wages is markedly lower than elsewhere 
in Peru, and diarrheal disease prevalence and under-five mortality are nearly three-times 
the national average (38).  
A birth cohort of 303 children was enrolled in Santa Clara de Nanay between 
November 2009 and February 2012. Details of data collection are reported elsewhere; 
briefly, date of birth, sex, breastfeeding initiation information and anthropometrics were 
collected at enrollment, which occurred within 17 days of birth. Children contributed 
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monthly surveillance stool samples for generation of asymptomatic infection history, and 
were visited twice-weekly for active surveillance of diarrhea which if present resulted in 
additional specimen collection. Active surveillance visits also ascertained illness and 
treatment (antibiotic) history, breastfeeding practices and dietary intake. Weight and 
length were measured monthly to generate calculate anthropometric measures. Analysis 
of routine and diarrheal stool specimens was conducted in the satellite laboratory in 
Iquitos, Peru according to unified MAL-ED protocol. Details of microscopy, bacterial 
culture methods, immunoassays and amplification methods to identify bacteria, protozoa 
and viruses across all eight sites have been published (39).  
In 2016 the Peru Microbiota Collaboration was established to conduct analyses of gut 
microbiota among children enrolled in MAL-ED Peru. Two-hundred and seventy-one of 
the 303 children initially enrolled contributed surveillance stools at 6, 12, 18 and 24m of 
age were selected for microbial analysis by the Gordon Laboratory at Washington 
University in St. Louis, Missouri. DNA was isolated from aliquots of pulverized, frozen 
fecal samples. Fecal samples were homogenized by bead beating for 4 minutes 
(MiniBeadbeater-96TM, Biospec Products; Bartlesville, Oklahoma USA) in a mixture of 
250 μL of 0.1 mm-diameter zirconia/silica beads (and a 3.97 mm-diameter steel ball for a 
subset of samples), 710 μL of 500:210 2X buffer A (200 mM NaCl, 200 mM Tris, 20 
mM EDTA):20%SDS, and 500 μL of 25:24:1 phenol:chloroform:isoamyl alcohol, pH-
adjusted to alkaline. Samples were then centrifuged at 3,220 x g for 4 min at room 
temperature.  350 uL of aqueous phase was transferred to a new tube containing 500 uL 
25:24:1 phenol:chloroform:isoamyl alcohol, pH-adjusted to alkaline. The tubes were 
inverted 10 times to mix and then centrifuged at 3220g X 4 min. 250 uL of aqueous phase 
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was transferred to a 96-well plate. DNA was purified from a 100 uL aliquot of each 250 
uL crude DNA sample by mixing 100 uL of crude DNA with 400 uL of a 675:45 mix of 
Qiagen® buffer PM:3M NaOAc, pH5.5 and then passing the mixture through a Qiagen® 
QIAquick96  plate by centrifugation at 3220g X at least 4 min. Wells were washed twice 
by passing 900 uL Qiagen® buffer PE through the plate by centrifugation at 3220g X at 
least 2 min. Quant-iT dsDNA Broad-Range Assay Kits (Invitrogen; Carlsbad, California, 
USA) was used to quantify the pure DNA. 
For each DNA sample, the V4 regions of bacterial 16S rRNA (V4-16S rRNA) genes 
present were amplified using previously published primers (25) and the following PCR 
conditions: an initial denaturation step of 2 min at 94°C, followed by 26 cycles of 15 sec 
at 94°C, 30 sec at 50°C, and 30 sec at 68°C, followed by a final step at 68°C for 2 min. 
Amplicons were sequenced using an Illumina MiSeq instrument. The resulting 250-
nucleotide paired-end reads were trimmed to 200 bases and merged with Flash, and 
QIIME (v 1.9.0) (40)was used to demultiplex the reads and cluster them into operational 
taxonomic units (OTU; clusters sharing ≥97% sequence identity). OTU that failed 
alignment by PyNast (41) were removed from the dataset. Taxonomy was assigned to 
each OTU using the Ribosomal Database Project (RDP) classifier version 2.4 (42) and 
the 2013 Greengenes reference database (43). The resulting OTU table contained 
32,300±16,453 (mean±sd) reads per sample. Subsequently, OTU that did not have 
relative abundances of ≥1% in at least one sample or ≥0.1% of the reads in at least two 
samples were removed from the data. The data were then rarefied to 11,000 reads per 
sample, and Shannon’s diversity index, the total phylogenetic diversity, and the observed 
number of OTU for each community were calculated as measures of microbial richness 
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and diversity. Samples that did not have at least 11,000 reads were removed from the 
data. 
 
Analytic approach.  
Definition of covariates. Diarrhea was defined as occurrence of ≥3 loose stools in a 24-
hour period, and distinct episodes classified as separated by either a pathogen negative 
stool or a period of ≥14 days since last diarrheal stool. The number of distinct episodes 
experienced by each child from enrollment to each outcome measure was analyzed as a 
cumulative, time-varying indicator of diarrheal frequency. Severity of episodes was 
assessed using a Community Diarrheal Assessment (CODA) score, with each episode 
assigned a score out of 15 points based on maternally reported presence and duration of 
fever, vomiting, anorexia, liquid stools, and the maximum number of stools in a 24-hour 
period at any time during the episode (44). Adjustment for potential confounders and 
assessment of interactions was conducted using various illness, treatment, dietary and 
growth indicators. Asymptomatic infections were considered using a cumulative time-
varying value denoting the mean number of enteropathogens identified per surveillance 
stool contributed at each point of follow-up. Antibiotic exposure was included as a 
continuous variable representing the number of days with any exposure in a child’s life. 
Breastfeeding frequency was considered as a continuous, cumulative average of the 
number of times the child was brought to the breast in the last 24 hours. Breastfeeding 
was also considered as a categorical variable indicating exclusive, predominant (other 
liquids) or partial (foods including solids) breastfeeding. Children were categorized as 
fully weaned from the day after their last reported breastmilk exposure. Dietary diversity 
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was measured continuously as the number of 7 WHO food groups that a child had ever 
ingested at each time of follow-up (45). Standardized length- and weight-for-age Z-scores 
were calculated at each month of life using the World Health Organization’s Multicentre 
Growth Reference Study Group guidelines (46). Children were classified as “born 
stunted” if their baseline measure was below -2 LAZ. Severe stunting was defined as 
LAZ measuring at or below -3 standard deviations.   
Microbial diversity and richness were assessed using four distinct metrics calculated 
using OTU identified in fecal samples. The Shannon Diversity Index (SDI) (47) accounts 
for the number and distribution of different species, and Simpson’s Diversity (48) 
describes the sum of the squared proportional abundances of all OTU within a given 
sample. Both are measures of alpha-diversity, or within-sample bacterial diversity, 
however the Shannon index was defined as the primary diversity metric a priori due to its 
equal sensitivity to rare and abundant species and because it is more widely used in the 
literature therefore useful for consistency and ease of comparison. Bacterial richness was 
measured by CHAO1 (49), which uses a capture-recapture method to enumerate species 
richness and phylogenetic diversity (50), expressed as the sum of all phylogenetic branch 
lengths represented within a sample.  
Statistical analyses. The impact of diarrheal frequency, duration and severity on 
subsequent microbial metrics throughout the first two years of life was estimated and 
tested using multiple linear regression (MLR) with a generalized estimating equations 
approach to adjust for within-child correlation over time. We investigated whether 
associations between diarrheal disease and microbial metrics endured over time using 
two distinct approaches. First, we examined time since last diarrheal insult as a predictor 
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of subsequent microbial indices using the same methodology as described above. Second, 
we repeated our analyses in a sub-cohort of children who were able to contribute stools at 
quarterly intervals at least one month after most recent diarrheal or antimicrobial 
perturbation. All models assessing relationships between diarrhea and microbial indices 
were adjusted for age, breastfeeding frequency and category, dietary diversity, antibiotic 
exposure and pathogen pressure.  
Across the full cohort, we assessed whether relationships between diarrheal disease 
and microbial metrics differed according stunting and weaning status. We hypothesized 
that i) stunted children may be more vulnerable to intestinal insult, and ii) that potential 
changes to the microbiota would be pronounced in the absence of breastmilk. For each of 
these analyses, interaction terms were added to the original MLR to assess whether 
relationships statistically differed across four categories of stunting (not stunted, stunted, 
severely stunted, born stunted) or weaning status (binary yes/no variable) across the 
population.  
Finally, we assessed whether diversity metrics at 6, 12, or 18m of age were associated 
with the number of subsequent diarrheal episodes experienced in infants’ lives. To do so, 
we ran MLR models separately at each time point and therefore excluded adjustment for 
within-child correlations, but retained all other potential confounders. 
 
RESULTS. 
Description of diarrhea in the population. Throughout follow-up, 146 boys and 125 
girls contributed 6,3031.4 months of person-time and a total of 6,011 surveillance stools 
and 2,440 diarrheal samples to the study. Seventy-seven percent of diarrheal samples 
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(1887) were pathogen-positive, with up to 7 distinct enteropathogens detected in a single 
sample.  Two-hundred and sixty children (95.9%) experienced diarrhea during follow up. 
Mean time to first episodes was 5.3 months, with a median of 4.6 months of age. By two 
years of age, children experienced a mean of 8.8 diarrheal episodes lasting on average 4 
days each. Most common enteropathogens identified in diarrheal stools were 
Campylobacter spp (32%), norovirus (27%), Giardia spp (25%), entero-aggregative E. 
coli (17%), and Cryptosporidium (10%). Time to first exposure and diarrheal prevalence 
at each age are shown in Figure 1; indices of diarrheal exposure and microbial diversity 
in each quarter of life are shown in Table 1. Figure 2 illustrates the increase in microbial 
indices with age from birth to two years of age.  
Description of covariates in the population. Children experienced a high prevalence of 
asymptomatic infections: 44% of surveillance stools were infected with at least one 
enteropathogen, and up to 6 pathogens were detected in a single sample by 2 years of age. 
Ninety-seven percent (262) of children in the cohort were exposed to antibiotics, with an 
average of 53 days of exposure in the first two years of life. Children underwent a mean 
of 9.3 distinct courses of treatment lasting an average of 6 days each.  
All 271 children in the cohort received breastmilk. Mean duration of exclusive 
breastfeeding was 41 days. However, switching back to exclusively breastfeeding for 
some period of time even after introduction of other liquids or foods was a common 
practice in this population, and the mean number of days with exclusive breastfeeding 
from 0-24m of age was 94. Mean age at introduction of solids and non-human milk were 
144 days (4.8m) and 172 (5.6m) days of age, respectively, and children were weaned at 
the average age of 593 days (19.5m). No children in the cohort were still exclusively 
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breastfed at 6m of age, and very little variation in breastfeeding habits were observed 
(See Table 1). By two years of age, 69% of children were exposed to all seven WHO 
complementary food groups, and all but one child were exposed to at least four of them 
(meeting a minimum dietary diversity standard (45)). Overall, 181 (66.8%) of the 271 
children included in the microbiota collaboration were stunted (LAZ<-2) and one in five 
children (22.1%) in the cohort were severely stunted (LAZ<-3) at least once throughout 
follow-up. Thirty-four children (12.6%) were stunted at enrollment, which occurred 
within 17 days of birth. Twenty-five of the 60 children who were severely stunted in the 
cohort were born stunted.  
Diarrhea, breastfeeding and growth in MAL-ED Peru. Diarrhea incidence increased 
with age in the first year of life, and decreased thereafter (Figure 1B). Due to the 
uniformity in breastfeeding habits across the cohort we could not model the relationship 
between diarrhea and breastfeeding according to the WHO recommended threshold of 6 
months of age. Instead, effects were stratified by year of life due to greater variation in 
breastfeeding habits after 12m of age (see Table 1). After adjustment for age and 
breastfeeding frequency, the odds of experiencing diarrhea was significantly increased in 
all categories relative to children who were still exclusively breastfed (Predominant OR: 
2.5, p=<0.001; Partial OR: 2.4, p<0.001; Weaned OR: 3.3, p=0.011) from 0-12m of age. 
In the second year of life, children who were weaned had higher odds of experiencing 
diarrhea than those children who were still partially breastfed (OR=1.2, p=0.045).  
Models assessing the impact of diarrhea on growth were adjusted for age, 
breastfeeding intensity and category, LAZ at birth, and pathogen pressure. Throughout 
the first two years of life, each additional diarrheal episode experienced was associated 
 100 
with a reduction in 0.01 LAZ (β= -0.01; p=0.002), after adjustment for age, breastfeeding 
frequency and category, and LAZ at birth. Odds of being severely stunted increased by 
8% with each additional diarrheal episode throughout the first two years of life 
(OR=1.08; p<0.001) throughout the cohort. 
Impacts of diarrhea on microbial diversity and richness. All metrics of diversity and 
richness increased significantly with age per month of life throughout follow-up 
(Shannon β=0.18, CHAO1: β=9.0, PD: β=0.65, Simpson β=0.03; p<0.001 for all indices). 
Frequency of exposure to breastmilk had a suppressive effect on diversity and richness, 
while weaning and dietary diversity significantly increased all measures (data presented 
in Chapter 4 of this dissertation).  
Table 2 describes associations between diarrheal disease history and microbial metrics 
from birth to 24m of age among 271 in the Santa Clara cohort. Cumulative diarrheal 
frequency had a significantly negative association with all four diversity indices after 
adjustment for age, breastfeeding and dietary factors, pathogen pressure and antibiotic 
exposure. Further, we found significant interaction between stunting status and diarrheal 
exposure: children who were born stunted experienced greater diversity insults per 
diarrheal episode than those children who were not stunted (Interaction terms, Shannon: β 
=-0.04, p=0.037; Simpson: β =-0.01, p=0.032). This was not seen among measures of 
bacterial richness (CHAO1: β =-1.21, p=0.239; PD: β =-1.0, p=0.179). Mean diarrheal 
duration and severity were significantly associated with reduced microbial diversity and 
richness throughout life (see Table 2), but there was no significant evidence that the 
relationship between diarrheal duration and severity and diversity indices differed by 
stunting or weaning status (p>0.5 for all interaction terms).  
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Finally, we modeled whether time since last diarrheal episode was associated with 
reduced diversity across the full cohort of 271 children. We observed that the mean 
number of days since last reported episode were higher in year two than in year one (97 
vs 49 days, respectively), during which the odds of experiencing diarrhea was lower 
(Figure1B). Given that this coincides with the marked increase in diversity in year two, 
we additionally adjusted these analyses for year of life. Each additional month of life 
since experiencing diarrhea was significantly associated with a mean increase of 0.02 
points on the Shannon diversity scale and 0.11 points in phylogenetic diversity (p=0.03 
and p=0.008, respectively). We additionally detected evidence that severely stunted 
children exhibited a significantly weaker association between time since diarrhea and 
increased microbial richness (Interaction terms: CHAO1: β= -4.12, p=0.040; PD: β= -
0.28, p=0.044) than those measuring at above -3 LAZ. While this negative trend was also 
apparent for diversity measures, it was not statistically significant (Shannon β= -0.06, 
p=0.105; Simpson β=-0.005, p=0.488).  
To further investigate whether associations between diarrhea and reduced diversity 
endure over time, we replicated analyses among children who had not experienced 
diarrhea or antibiotic exposure for at least one month before contributing stool samples. 
A total of 71 children (39 boys and 32 girls) contributed 430 diarrheal samples and 1840 
surveillance stools for the calculation of illness and infection history, and 254 samples for 
16S microbial analysis after being free of diarrheal or antimicrobial perturbation for at 
least 30 days. Indices of diarrheal disease, microbial diversity and richness, and illness 
and dietary covariates for this sub-cohort are shown in Supplementary Table 1. Children 
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in this group were similar to the broader cohort, with the exception of reporting fewer 
diarrheal episodes and days with antibiotic exposure relative to the broader cohort.   
We observed a negative relationship between diversity and number of diarrheal 
episodes in this group, but this was only statistically significant for the Shannon index 
(Figure 3; Table 3). Each additional diarrheal episode experienced was associated with a 
reduction in 0.05 points on the Shannon Diversity Index at least one month after insult. 
Similarly, severity of episodes exhibited a negative trend on all indices, but this only met 
the threshold of statistical significance for the Shannon Index, which was reduced by an 
average of 0.01 per one-point increase in the CODA severity score. In contrast, we found 
that mean duration of reported episodes was significantly associated with reduced 
microbial diversity and richness after lagging exposures, with each additional day of 
diarrhea associated with reductions Shannon, CHAO1 and phylogenetic diversity scores 
that endured >1m after symptoms resolved. 
Impacts of microbial diversity and richness on subsequent diarrhea. We found 
significant evidence that reduced microbial diversity and richness was predictive of more 
frequent subsequent diarrhea in the full cohort of 271 children. At 6m of age, each 
additional point on the Shannon and Simpson’s diversity metrics was associated with a 
mean reduction of 1.3 and 3.4 diarrheal episodes from 6-24m of age, respectively (Table 
4). At one year of life, higher Shannon, CHAO1 and phylogenetic diversity scores were 
significantly associated with reduced subsequent diarrhea. While this negative trend was 





We describe longitudinal, bi-directional associations between four metrics of bacterial 
diversity and diarrheal disease in a large birth cohort with a high burden of undernutrition 
and enteric infections. Patterns between covariates in this cohort were consistent with the 
wider body of literature demonstrating the protective effects of breastfeeding on the risk 
of diarrheal disease (51), and the detrimental associations between diarrhea and 
subsequent child growth (52,53). In a population illustrating the classical cycle of 
diarrhea and undernutrition we report evidence that disruptions to the gut bacterial 
community may be implicated in driving the repeated cycle of diarrheal disease 
experienced by vulnerable children during a critical period for growth and development.  
Diarrheal frequency, duration and severity were all significantly associated with 
reductions in gut microbial diversity and richness. These findings are complementary to a 
case-control study of 992 children comparing stools of children with moderate to severe 
diarrhea in West Africa and South Asia enrolled in the GEMS study to non-diarrheal 
controls. This work, which comprises the largest sample size in a study assessing this 
relationship in LMIC, demonstrated that diarrheal samples consistently exhibit reduced 
Shannon diversity relative to controls (36). Our study uses a longitudinal design to 
demonstrate that these disparities extend beyond the diarrheal episode itself, and are 
apparent among non-diarrheal samples contributed by children with greater lifetime 
history of disease. This is also consistent with recent findings from studies conducted 
among children in Nicaragua and Vietnam. In the former, samples were collected during 
and 2 months after diarrheal disease among 25 Nicaraguan children of mean age 21 
months (54). Authors report no increase in diversity or richness in the 2 months following 
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diarrhea, which is counter to the acquisition curves expected in the developing gut. When 
separated by pathogen positivity, they further noted that children with pathogen-free 
diarrhea did exhibit increases in phylogenetic diversity and species richness, whereas 
those with enteropathogens detected in diarrheal samples did not. In Vietnam, authors 
identified four distinct profiles of the gut assembly among 55 samples from controls and 
145 samples from diarrheal hospital patients under 5 years of age (55), two of which were 
nearly exclusively comprised of diarrheal cases. While they did not find a clear pattern of 
Shannon diversity aligning with diarrheal symptoms, their classification of particular taxa 
showed the degree of divergence from the healthy gut community to be correlated with 
diarrheal output and hospital duration, implying that severity of disease may be 
associated with microbial disruption. Authors further observed a depletion of taxa that 
produce short chain fatty acids, and postulated that this may contribute to shortages in 
absorption and metabolic energy that can help explain long term sequelae of diarrheal 
disease.  
We also report evidence that apparent impacts on diversity endure beyond one month 
after diarrheal exposure in a subset of children, and that time elapsed since most recent 
diarrheal episode was associated with regeneration of the diversity and richness metrics 
across the full population. This finding may appear at odds with prior observations that 
the gut microbial community exhibits transient changes followed by apparent recovery 
one month after diarrheal insult in Bangladesh (25,56). In these studies, patients with 
severe disease were enrolled and their recovery was characterized after a single, moderate 
to severe episode either cholera or enterotoxigenic Escherichia coli (ETEC). In our 
cohort, the magnitude of gains in microbial metrics associated with a one-month recovery 
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period was similar to the magnitude of depletion associated with a single episode. 
Therefore, these findings do not necessarily conflict; the microbial community may 
recover within one month if the exposure is a single episode of diarrhea. Our data 
however describes the impacts of repeated disease with multiple episodes of infection and 
symptoms throughout life, which may explain the more lasting impacts observed.  
Slower recovery in diversity and richness was observed among children who were 
severely stunted. As such, children experiencing multiple episodes in the first two years 
of life may risk experiencing additive insults to microbial indices that are already 
diverging from their anticipated trajectory, and this may be even more consequential 
among children suffering from severe growth deficits. Furthermore, we found that high-
risk subsets of children were more susceptible to microbial perturbations following 
diarrheal insult. Children who were born stunted and children weaned before two years of 
age exhibited more profound reductions in microbial metrics than the broader population. 
Our group recently showed that diversity acquisition was slowed among children born 
stunted, and that this was exacerbated among those children receiving no breastmilk; 
these findings further illustrate the apparent microbial vulnerability to insult observed 
among this group. These observations together may illustrate a possible mechanism 
through which children with intrauterine growth restrictions experience long term 
immunological and growth deficits, and merits further research. Further, it underscores 
the need to reinforce existing recommendations regarding continued breastfeeding to two 
years, rather than focusing only on exclusive breastfeeding in the first 6 months of life.  
In contrast to the prior literature, our study was able to leverage longitudinal data and 
additionally detect associations between compromised microbial metrics and subsequent 
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diarrheal incidence, lending further weight to the hypothesis that perturbations to gut 
microbiota may be a factor in driving the cyclical pattern of repeated diarrheal disease in 
early life. The majority of evidence demonstrating the association between gut 
perturbations and susceptibility to diarrheal disease has been derived from describing 
opportunistic C. difficile infections thriving in the diminished gut community following 
antibiotic treatment. Recent evidence has also implicated the presence and abundance of 
particular taxa in facilitating Campylobacter colonization (57–60). Here, we provide 
evidence that reduced microbial diversity is associated with increased subsequent 
frequency of all-cause diarrhea, after adjustment for other key predictors of illness such 
as breastfeeding intensity and category, asymptomatic pathogen pressure, dietary 
diversity and anthropometric status. While this does not denote causality, our study is 
able to illustrate temporal trends that have not been demonstrated before.  
Taken together, this illustrates a growing body of evidence implicating disruptions to the 
gut microbiota as a potential mechanism through which diarrheal disease enacts long-
term consequences for child health. Other studies described have also found significant 
associations between diarrheal disease and relative abundance of particular taxa, and 
highlighted the role of specific pathogens as predictors of microbial outcomes, providing 
impetus to conduct further analyses within the extensive MAL-ED data repository, in 
Peru and other sites, to characterize these relationships in more detail. Disaggregating 
exposures by pathogen and also by kind of diarrhea, ie, invasive or inflammatory, will 
also serve to further clarify the observed findings. Given the failure of water, sanitation 
and hygiene interventions to reduce diarrheal disease transmission and improve child 
growth, this is an important avenue for future research that may yield novel therapeutic 
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Table 1: Diarrhea, growth, breastfeeding practices and gut microbial indices at each quarter of life in 
the Santa Clara birth cohort, Peru (n=271) 
 Mean (SE) or % (n); 95% CI 
Diarrheal disease exposures 6m 12m 18m 24m 




































 % diarrheal stools with at least 









     
Linear growth (LAZ)     


























     
Breastfeeding categories     
% (n) exclusively breastfed 0 0 0 0 
% (n) predominantly breastfed 3 (8) 0 0 0 
% (n) partially breastfed 96 (254) 94 (228) 52 (114) 16 (32) 
% (n) weaned 1 (2) 5 (13) 48 (107) 84 (173) 
     
Microbial diversity indices     






































Table 2: Associations between diarrheal disease and gut diversity and richness outcomes in the Santa Clara cohort (n=271) 
 Mean change in Microbial Metrics 
 Shannon 
 
CHAO1 Phylogenetic Diversity 
 
Simpson 
 β (SE); 95% Confidence interval 












     












     
Mean severity of diarrheal 











     










All associations were adjusted for age, breastfeeding intensity and category, dietary diversity, antibiotic exposure, pathogen pressure. Time since last 





Table 3: Associations between diarrheal disease and microbial indices in sub-cohort of children with lagged diarrhea and antibiotic exposure 
(n=71) 
 Mean change in Microbial Metrics 
 Shannon 
 
CHAO1 Phylogenetic Diversity 
 
Simpson 
 β (SE); 95% Confidence interval 











-0.014, 0.001  
     












     
Mean severity of diarrheal 











All associations were adjusted for age, breastfeeding intensity and category, dietary diversity, antibiotic exposure, pathogen pressure. Findings 











CHAO1 Phylogenetic Diversity 
 
Simpson 
 β (SE); 95% Confidence interval 













-0.29, -0.03  
-1.76 (1.18) 
-4.08, 0.56 








Coefficients represent mean change in the number of subsequent diarrheal episodes experienced accompanying a 1-point increase in each microbial 
metric. All associations were adjusted for breastfeeding intensity and category, dietary diversity, antibiotic exposure, pathogen pressure, age and LAZ 
at birth. Findings significant at the p<0.05 threshold are shown in orange.  
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Supplementary Table 1: Diarrhea, growth, breastfeeding practices and gut microbial indices at each 
quarter of life in sub-cohort for analysis of lagged exposures (n=71) 
 Mean or % (SE); 95% CI 
Diarrheal disease exposures 6m 12m 18m 24m 































1.9, 2.4  
2.0 (0.1) 
1.8, 2.2 










     
Linear growth (LAZ)     
























     
Breastfeeding categories     
% (n) exclusively breastfed 0 0 0 0 
% (n) predominantly breastfed 4 (3) 0 0 0 
% (n) partially breastfed 96 (68) 96 (68) 44 (31) 13 (9) 
% (n) weaned 0 4 (3) 56 (40) 87 (62) 
     
Microbial diversity indices     
























Simpsons Diversity 0.4 (<0.1)  
0.4, 0.5 
0.7 (<0.1)  
0.6, 0.7 
0.8 (<0.1)  
0.8, 0.9 
0.9 (<0.1)  
0.9, 0.9 
 113 
Figure 1: Time to first diarrheal episode (a) and proportion experiencing diarrhea at each month of 
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Chapter 6: Gut microbial members indicative of Campylobacter burden 
and linear growth shortfalls in a peri-urban community in Peru 
 
ABSTRACT.  
Background. Interactions between enteric infections and undernutrition continue to drive 
mortality and morbidity among children living in poverty. Infection with enteropathogens 
like Campylobacter spp. results in growth impairment and other long-term disabilities 
even in the absence of symptoms, and it has been posited that changes incurred to the gut 
microbiota during or after infection may in part explain these sequelae. No studies have 
specifically assessed the potential changes to the gut environment incurred by 
Campylobacter infections among young children in poverty, who suffer the undue burden 
of the cycle between undernutrition and infection. We evaluate associations between 
Campylobacter infections, linear growth, and features of the fecal microbial community 
in a birth cohort of 271 children living in Amazonian Peru.  
Methods.  Routine fecal samples at 6, 12, 18 and 24m of age (n=928) were used to 
identify gut bacterial taxa by polymerase chain reaction (PCR) detecting 16S ribosomal 
RNA, and generate metrics of diversity and richness (Shannon, Simpson, CHAO1 and 
Phylogenetic diversity). Asymptomatic surveillance stools were collected monthly from 
0-12 month and quarterly thereafter for identification of Campylobacter using enzyme-
linked immunoassays (ELISA).  Diarrheal samples were ascertained during each reported 
episode from 0-24m of age. 
Monthly anthropometric measurements were collected to calculate standardized length-
for-age Z-scores (LAZ).  Associations between symptomatic and asymptomatic 
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Campylobacter infections, community and species-level microbial metrics, and child 
growth were investigated using multiple linear regression with adjustment for within-
child correlations, age, breastfeeding and infection with other pathogens. Indicator 
species analysis was employed to identify possible gut taxa associated with 
Campylobacter infections.  
Results.  By two years of age, 251 (93%) of all children in the cohort had Campylobacter 
present in asymptomatic stools, and 221 (82%) experienced infection with diarrhea. 
Asymptomatic infection was associated with reductions in length-for-age concurrently 
and at 3, 6, and 9m thereafter (β=0.02, p<0.01 across all time points).  Each additional 
episode of Campylobacter-diarrhea was associated with a concurrent reduction in -0.03 
LAZ (p=0.002), independently from all-cause diarrhea. Asymptomatic Campylobacter 
infections were associated with changes to the gut microbial environment.  Infection was 
associated with increased microbial diversity and richness.  Indicator species analysis 
identified thirteen taxa indicative of being in the highest quartile of infection from birth to 
two years of age, three of whose presence showed evidence of association with lower 
concurrent LAZ.  Nine additional indicators of low Campylobacter burden were 
identified, the majority of which were butyrate-producing Firmicutes.  Presence or 
abundance of four taxa indicative of low infection burden was associated with higher 
LAZ concurrently and one month thereafter. 
Conclusions. Campyobacter spp infections were nearly universal among children in the 
Peruvian Amazon in the first two years of life. We illustrate changes to gut microbial 
populations associated with asymptomatic infection in a longitudinal study with a large 
sample size and generate testable hypotheses for future research to guide interventions 
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related to the improved control of Campylobacter and mitigation of its adverse effects on 
growth in infancy and early childhood.   
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INTRODUCTION.  
 Interactions between enteric infections and undernutrition and their toll on quality of 
life and survival of young children in lower and middle-income countries (LMIC) have 
been extensively described over the last several decades (1,2,11,3–10). Nonetheless, 
childhood stunting, or chronic undernutrition, continues to affect over 160 million 
children annually and underlie a vast proportion of child deaths worldwide (12,13).  The 
aggregate effect of interventions aimed at improving child growth has been 
disappointing, and it is widely accepted that understanding of the mechanisms driving 
these interactions remains incomplete (14).  This has led to increased interest in research 
specifically elucidating pathways through which enteric infections may drive stunting and 
its long-term consequences for vulnerable children worldwide in order to guide more 
effective interventions. An altered intestinal state known as environmental enteropathy 
(EE), characterized by intestinal and systemic inflammation and increased gut 
permeability, is proposed to play an important role in propagating the cycle of enteric 
infections and undernutrition (15–17). In recent years, a growing body of evidence has 
linked physiologic features of gut immune activation and permeability measures to long-
term growth deficits and blunted immune responses, including vaccine failure (18–22).  
That EE can arise from chronic or repeated infections in the absence of diarrheal 
symptoms may help to explain persisting linear growth failure in settings where programs 
to prevent and treat clinical diarrhea and provide nutritional supplementation are well-
implemented (13,15).  
 Infection with Campylobacter spp. has been suggested to illustrate the EE hypothesis 
for multiple reasons.  In high-income settings where infection is the leading cause of 
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bacterial gastroenteritis (23–25), there is extensive literature detailing long-term 
sequealae of disease.  Studies linking infection to chronic conditions like Guillan-Barré 
syndrome, reactive arthritis, inflammatory bowel disease and irritable bowel syndrome 
have demonstrated that Campylobacter infections can impact immunological tolerance 
and gut permeability and function well beyond the cessation of acute symptoms (26–34). 
While data in LMIC is more limited, recent work has shown that symptomatic and 
asymptomatic infection are independently associated with linear growth acquisition in the 
subsequent three-month period, and that children with high burden are significantly 
shorter at two years of age (35,36). Observational and more recently metagenomic 
analysis confirms that prevalence of Campylobacter infections and presence of 
Campylobacteraceae in the gut are significantly increased in undernourished children 
(37–39). These observations are even more relevant in light of recent estimates of higher 
asymptomatic carriage and attributable fraction of diarrhea to Campylobacter spp., and a 
wider range of species with clinical outcomes than previously appreciated (36,40–42).  
Indeed, the first large multi-site study to employ culture-independent diagnostic 
methodology to enumerate this burden found Campylobacter to have the highest bacterial 
attributable fraction of diarrhea, a high prevalence of asymptomatic carriage and 
significant associations between infection, increased systemic inflammation and 
increased intestinal permeability (36,40,42).  
 Together these findings have led to the suggestion that Campylobacter may be an 
illustrative example of how enteric infections can impair growth through the mechanism 
of EE (36). However, a more complete description of how enteropathogens may drive the 
EE phenotype, particularly when they occur in the absence of clinical symptoms is 
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needed. One putative pathway is through enacting changes to the microbial ecology of 
the gut, which in turn may disrupt the integrity and functioning of intestinal immunity 
and nutrient harvest. Extensive animal and in vitro studies have illustrated the role of gut 
microbiota in maintaining healthy immune responses and gut barrier integrity (43–46), 
key features altered in EE, and experimental studies show improved immunogenicity to 
enteric vaccines after exposure to different pre- and probiotic strains in mice (47–49). Gut 
microbiota are also known to affect nutrient and energy harvest (50–53) and are 
increasingly implicated in child growth.  Induction and reversal of weight gain can be 
achieved by inoculating germ free mice with fecal specimens from children of different 
growth profiles (52,54–56), and human studies have found differences in presence and 
abundance of specific phyla and reductions in overall bacterial diversity among children 
with severe acute malnutrition (54,57–59).  
 It is therefore plausible that consistent exposure to enteropathogens disrupts 
childhood immunity and growth in part through the alteration of gut microbiota.  Indeed, 
studies have shown that diarrhea can have lasting impacts on gut microbial populations 
(60–64), though most have enrolled adults in high-income settings.  Two large-scale 
studies of children in LMIC settings have recently suggested that taxonomic composition 
and microbial diversity were significantly compromised during and after diarrheal disease 
(65), that these changes were exacerbated by severity and duration of symptoms and can 
endure beyond one month after clinical disease. In the case of Clostridium difficile 
infection, researchers observed that asymptomatic carriers also had significantly reduced 
microbial diversity relative to healthy patients (66); however, this study enrolled fewer 
than 10 individuals per arm, whose ages ranged from 25 to 86 and whose comorbidities 
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were not matched.  No other studies specifically evaluating impacts of asymptomatic 
enteric infection on gut microbial members or assembly are available to our knowledge.  
 The evidence described supports the hypothesis that gut microbiota are an important 
factor in determining the complex interplay between infection, diarrhea, immunological 
responses and child growth, but to advance this theory key gaps in research must be 
addressed.  A more complete description of the possible impacts of clinical and 
subclinical infections on the gut microbial community are needed, followed by an 
evaluation of whether these potential changes are implicated in key inflammatory or 
metabolic pathways that may drive long-term health deficits. The current study proposes 
to explore these questions using data from a community-based longitudinal birth cohort 
in Amazonian Peru. We describe the magnitude and direction of associations between 
Campylobacter infection and diarrhea, linear growth, and fecal microbial diversity and 
composition with an aim to contribute to evidence of the putative pathways between 
intestinal infection and growth failure in early childhood. 
 
METHODS.  
Study design & setting.  This study was nested within the Etiology, Risk Factors, and 
Interactions of Enteric Infection and Malnutrition and the Consequences for Child Health 
and Development (MAL-ED) Study, a longitudinal study based in eight settings 
characterized by high childhood undernutrition and diarrhea (67). The Peru Microbiota 
Collaboration was formed between Asociación Benéfica PRISMA in Iquitos, Peru, the 
Johns Hopkins Bloomberg School of Public Health in Baltimore, MD, and the Gordon 
Laboratory at Washington University in St. Louis, MO in 2016 to characterize the role of 
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the infant gut microbiota in interactions between enteric infections and nutritional 
indicators that MAL-ED was enacted to explore. Detailed methodology of the collection 
of demographic and demographic data, biological specimens and their analysis is 
therefore available in the extensive literature published by the MAL-ED Consortium 
(15,67–71).  In brief, the research site from which data was ascertained for this study is 
located in a peri-urban community in the Amazonian lowlands of Iquitos, Peru, which is 
marked by low access to water and sanitation and high incidence of diarrheal disease and 
childhood stunting. Three-hundred and three children across three local communities 
were enrolled within 17 days of birth and followed to two years of age between 
November 2009 and February 2012. These children contributed routine stool samples for 
surveillance of asymptomatic enteric infections at monthly intervals during the first year 
of life, and quarterly intervals thereafter (15, 18, 21 and 24m of age). Weight and length 
were also measured monthly for the calculation of nutritional growth indices.  
Community members trained as fieldworkers visited the homes of all participants twice 
weekly to record illness and treatment (antibiotic) history, breastfeeding behaviors and 
dietary intake.  In the case of reported diarrheal illness, additional stool samples were 
taken for the diagnosis of clinical disease. Routine stools collected at 6, 12, 18 and 24m 
of age were retrospectively selected for inclusion in the Peru Microbiota Collaboration 
and sent to the Gordon Laboratory in St. Louis. 
 
Diagnostics and microbial analysis.  Upon initial collection, stool samples were 
placed into Cary-Blair transport media within two hours of production and processed in 
the satellite laboratory in Iquitos the same day. Campylobacter were identified in fecal 
 127 
samples using a ProSpecT Campylobacter enzyme-linked immunosorbent assay 
(ELISA).  While culture methodology was also available and carries the advantage of 
species differentiation, the MAL-ED study was the first to reveal the considerably 
increased burden of Campylobacter using culture-independent methods. Details of 
diagnostic assays for other enteropathogens are detailed and published elsewhere (71). 
Stools selected for inclusion in the Peru Microbiota Collaboration were additionally 
processed at Washington University in St. Louis, Missouri for analysis of the gut 
microbiota.  DNA was isolated from aliquots of pulverized, frozen fecal samples. Fecal 
samples were homogenized by bead beating for 4 minutes (MiniBeadbeater-96TM, 
Biospec Products; Bartlesville, Oklahoma USA) in a mixture of 250 μL of 0.1 mm-
diameter zirconia/silica beads (and a 3.97 mm-diameter steel ball for a subset of 
samples), 710 μL of 500:210 2X buffer A (200 mM NaCl, 200 mM Tris, 20 mM 
EDTA):20%SDS, and 500 μL of 25:24:1 phenol:chloroform:isoamyl alcohol, pH-
adjusted to alkaline. Samples were then centrifuged at 3,220 x g for 4 min at room 
temperature.  350 uL of aqueous phase was transferred to a new tube containing 500 uL 
25:24:1 phenol:chloroform:isoamyl alcohol, pH-adjusted to alkaline. The tubes were 
inverted 10 times to mix and then centrifuged at 3220g X 4 min. 250 uL of aqueous phase 
was transferred to a 96-well plate. DNA was purified from a 100 uL aliquot of each 250 
uL crude DNA sample by mixing 100 uL of crude DNA with 400 uL of a 675:45 mix of 
Qiagen® buffer PM:3M NaOAc, pH5.5 and then passing the mixture through a Qiagen® 
QIAquick96  plate by centrifugation at 3220g X at least 4 min. Wells were washed twice 
by passing 900 uL Qiagen® buffer PE through the plate by centrifugation at 3220g X at 
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least 2 min. Quant-iT dsDNA Broad-Range Assay Kits (Invitrogen; Carlsbad, California, 
USA) was used to quantify the pure DNA. 
For each DNA sample, the V4 regions of bacterial 16S rRNA (V4-16S rRNA) genes 
present were amplified using previously published primers (59) and the following PCR 
conditions: an initial denaturation step of 2 min at 94°C, followed by 26 cycles of 15 sec 
at 94°C, 30 sec at 50°C, and 30 sec at 68°C, followed by a final step at 68°C for 2 min. 
Amplicons were sequenced using an Illumina MiSeq instrument. The resulting 250-
nucleotide paired-end reads were trimmed to 200 bases and merged with Flash, and 
QIIME (v 1.9.0) (72) was used to demultiplex the reads and cluster them into operational 
taxonomic units (OTU; clusters sharing ≥97% sequence identity). OTU that failed 
alignment by PyNast (73) were removed from the dataset. Taxonomy was assigned to 
each OTU using the Ribosomal Database Project (RDP) classifier version 2.4 (74) and 
the 2013 Greengenes reference database (75). The resulting OTU table contained 
32,300±16,453 (mean±sd) reads per sample. Subsequently, OTU that did not have 
relative abundances of ≥1% in at least one sample or ≥0.1% of the reads in at least two 
samples were removed from the data. The data were then rarefied to 11,000 reads per 
sample, and Shannon’s diversity index, the total phylogenetic diversity, and the observed 
number of OTU for each community were calculated as measures of microbial richness 
and diversity. Samples that did not have at least 11,000 reads were removed from the 
data. 
Analytic approach.   
Definition of covariates. Diarrhea was defined as ≥3 loose stools in a 24-hour period, 
with distinct episodes separated by either a pathogen negative stool or a period of ≥14 
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days without symptoms. Diarrheal severity was measured using a community diarrheal 
assessment tool (76) classifying severity as a function of maternally reported presence 
and duration of fever, vomiting, anorexia, liquid stools, and the maximum number of 
stools in any 24-hour period during the episode.  Detection of enteropathogens in 
surveillance stools in the absence of diarrheal symptoms was considered asymptomatic 
infection.  ‘Pathogen pressure’ was defined as an aggregate measure denoting 
asymptomatic infections and was calculated as mean number of enteropathogens per 
surveillance stool contributed.  Breastfeeding was considered using a categorical metric 
denoting whether a child was currently being exclusively, predominantly, or partially 
breastfed or weaned, according to WHO definitions (77).  The number of WHO food 
groups (0-7) that a child had ever ingested at each time of follow-up was included as a 
measure of dietary diversity (77).  Standardized length-for-age Z-scores (LAZ) were 
calculated using the World Health Organization’s Multicentre Growth Reference Study 
Group guidelines, with children measuring at below -2 LAZ classified as stunted (78). 
 Campylobacter diarrhea was considered as a continuous variable denoting the number 
of distinct Campylobacter-positive diarrheal episodes experienced in a child’s life at 
given time point. Asymptomatic Campylobacter infection was assessed using an 
aggregate, time-varying variable expressing the proportion of all surveillance stools 
contributed by a single child with Campylobacter detection.  Using this proportion, we 
also calculated quartiles of asymptomatic Campylobacter burden at each quarter of life.  
We defined persistent asymptomatic infection as three consecutive monthly infections in 
the first year of life; we were unable to estimate the burden of persistent infections in the 
second year of life due to absence of monthly measures.  
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 We assessed community-level indicators of the infant gut microbiota using four 
metrics of within-sample (alpha) diversity and richness. The Shannon Diversity Index 
(SDI) (79) accounts for the number and distribution of different species, and Simpson’s 
Diversity (80) describes the sum of the squared frequency of all OTU within a given 
sample. Bacterial richness was measured by the CHAO1 metric(81), which uses a 
capture-recapture method to enumerate species richness, and by taking the sum of all 
phylogenetic branch lengths represented within a sample as a measure of phylogenetic 
diversity (82).  To explore changes to individual members of the gut microbial 
community, we modeled presence and abundance of individual OTU as outcomes of 
infection and as predictors of linear growth.   
Statistical analyses. Descriptive analysis of Campylobacter infection and diarrhea was 
conducted using Kaplan Meier curves and survival analysis allowing for multiple failures 
per child.  Associations between infection, diarrhea, and child growth were measured 
using multiple linear regression (MLR) with a generalized estimating equations (GEE) 
approach to adjust for within-child clustering.  Growth models were adjusted for 
breastfeeding, dietary diversity, diarrhea, pathogen pressure and antibiotic exposure 
(number of days with any exposure).  Models with concurrent LAZ as the outcome were 
adjusted for LAZ at birth; analyses modeling subsequent LAZ (at 1, 3, 6, 9m thereafter) 
were adjusted for LAZ at current time point.  
We employed the same methodology (MLR with GEE) to describe associations 
between Campylobacter infection and diarrhea on metrics of microbial diversity and 
richness from birth to two years of age. Microbial diversity and richness models were 
adjusted for age as well as metrics of breastfeeding, diet and antibiotic use defined above. 
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To ascertain whether Campylobacter had an independent effect on these metrics, models 
with asymptomatic infection and diarrheal episodes as predictors were additionally 
adjusted for proportion of surveillance stools with any enteropathogens and number of 
all-cause diarrheal episodes, respectively.   
To assess relationships between Campylobacter exposure and specific fecal OTU, we 
conducted Indicator Species Analysis (ISA) comparing children in different categories of 
asymptomatic infection and diarrhea burden. ISA (83) is a statistical procedure 
identifying particular OTU that are significantly indicative of a particular group of 
samples identified by a priori characteristic of interest. Indicator species values are 
calculated for every OTU for each group of communities, as the product of the proportion 
of communities in a group in which the OTU is detected and the mean abundance of the 
OTU in that groups, normalized to the sum of mean abundances in all groups. The values 
generated range between 0 and 1, with a perfect indicator species occurring only in one 
group.  Very common conserved species that occur in all groups are poor indicators, as 
are very rare species that are not sampled often.  Hypothesis tests are performed by 
permutations in which samples are randomly assigned to groups to generate a distribution 
of values; the null hypothesis is supported if the distribution of values does not differ in 
the test case when compared to those generated though permutations (83). OTU not 
found in at least 20% of the children in at least one of the Campylobacter infection 
groups were excluded from the analysis.   
ISA was conducted to identify possible OTU denoting recent Campylobacter-positive 
diarrheal history comparing the following groups: Campylobacter – positive versus 
negative diarrheal stools; stools contributed by children with versus without diarrhea in 
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the last 7 days; and stools contributed by children with versus without diarrhea in the last 
14 days.   Iterations of ISA were conducted at each time point to assess asymptomatic 
Campylobacter history: comparison of Campylobacter – positive versus negative 
surveillance stools, and comparison of stools contributed by children in the highest versus 
lowest quartile of asympomatic Campylobacter burden.  We replicated these analyses 
using groups defined by exposure of the next three most prevalent enteropathogens in the 
cohort (Giardia spp., entero-aggregative Escherichia coli (EAEC), and norovirus) in 
order to provide a platform for comparison of the number and nature of indicator species 
that may be identified in this cohort.  Adjusted p-values were derived using a Benjamini-
Hochberg method to correct for false discovery rates arising from multiple comparisons 
(84).   
To advance our enquiry as whether modification of gut microbes by Campylobacter 
infection may be implicated in the observed relationships between Campylobacter and 
child growth, we explored whether outputs of the ISA were independently associated 
with LAZ scores and stunting from birth to two years of age.  We built MLR models 
using individual OTU identified as indicative of Campylobacter burden as predictors of 
concurrent and future (+1m) LAZ and stunting in a model adjusting for age, LAZ at birth, 




Campylobacter infection and diarrhea in the population.  Two-hundred and seventy-
one (89.4%) of the 303 children were included in the Peru Microbiota Collaboration; the 
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remaining 32 children who were not included were lost to follow-up prior to 6m of age.  
In total, 146 boys and 125 girls contributed 6096 months of person-time under follow-up, 
6011 surveillance stools and 2440 diarrheal samples to the study. Using ELISA as the 
gold standard, we observed only 22% (364) of Campylobacter-positive stools yielded an 
isolate identified as Campylobacter by culture methods, and this proportion was 
unchanged when we stratified by specimen type (22% in both diarrheal samples and 
surveillance stools).  Campylobacter jejuni, or hippurate positive isolates, accounted for 
half of all culture-positive specimens (48%), and observation was again consistent across 
surveillance and diarrheal samples alike (45% of diarrheal samples and 48% of 
surveillance stools).   
Campylobacter infections were common and often persistent.  Campylobacter spp 
was detected in approximately one-fifth of all surveillance stools tested (22%, 912 
samples). By two years of age, 251 (93%) of all children in the cohort experienced at 
least one Campylobacter detection in the absence of symptoms.  Mean time to first 
infection was 7.8 months, and the majority of children (64%, 169 children) were 
Campylobacter-positive in surveillance stools before ever presenting with 
Campylobacter-positive diarrhea.  Table 1 summarizes Campylobacter infection and 
diarrhea at each quarter of life from birth to two years of age. Infection was more 
prevalent in the second year of life, though the odds of detection in the first year 
increased significantly with each additional month of age (OR 1.21, p<0.001).  The 
burden of infection was skewed across the cohort; mean number of infections among 251 
children was 3.4, but 44 children experienced >5 infections and 5 children experienced 
>10 infections before their 2nd birthday. We additionally observed that 55 children 
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(20.3%) experienced persistent Campylobacter infections in the first year of life.  Sixty-
nine (8%) of the 868 Campylobacter-positive surveillance samples were collected while 
children were being treated with any antibiotics, with 2% (21 samples) specifically 
collected during concurrent macrolide exposure.   
Of the 260 children who experienced diarrhea in the cohort, 221 (85%) contributed at 
least one specimen in which Campylobacter was detected. In total, Campylobacter was 
detected in 31% (758) of samples taken during reports of diarrhea in the first two years of 
life.  Mean age at first reported Campylobacter-positive diarrhea was 9.3 months.  
Children experienced an average of 2.6 episodes of Campylobacter-positive diarrhea by 2 
years of age; however, this was highly variable between children, ranging from 0 – 15 
detections.  Approximately a quarter of episodes were treated with antibiotics (27.3%, 
169 episodes) overall, with 15% (93 episodes) were treated with macrolides.  
Campylobacter infections and linear growth.  Campylobacter infection and diarrhea 
were associated with reduced child growth.  After adjustment for breastfeeding frequency 
and status, diarrhea, antibiotic exposure, pathogen pressure, and LAZ at birth, children 
had, on average, a 0.01 lower LAZ score associated with a 10% increase in the proportion 
of asymptomatic stools with Campylobacter detected. When we repeated these analyses, 
adjusting for LAZ at current time point, a 10% increase in detections was associated with 
a 0.02 reduction in LAZ at 3, 6, and 9 months thereafter (β=0.02, p<0.01 across all time 
points).  Campylobacter-positive diarrhea was associated with growth independently 
from all-cause diarrhea.  In a model adjusting for number of diarrheal episodes, mean 
number of pathogens detected per surveillance stool, antibiotic exposure, and 
breastfeeding intensity and category each additional episode of Campylobacter-diarrhea 
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was associated with a reduction in -0.03 LAZ (95% CI -0.04, -0.01; p=0.002).  However, 
this was not found when we modeled impacts of episodes on future LAZ thereafter.  
Associations between Campylobacter spp infection, diarrhea and gut microbial 
features. 
Microbial richness and diversity.  We did not observe metrics of microbial diversity and 
richness to be associated with lifetime history of Campylobacter infections or diarrhea 
independently from overall infection and disease history (Table 2).  There was no 
evidence that Campylobacter-specific diarrheal severity or duration had an independent 
effect on these metrics, after accounting for diarrhea with other etiologies.  Metrics of 
microbial diversity and richness were positively associated with Campylobacter detection 
in the absence of diarrhea, independently of overall asymptomatic pathogen pressure and 
frequency. 
Indicator Species Analysis.  We conducted indicator species analyses (ISA) at 6, 12, 18 
and 24m of age to identify possible taxonomic units significantly associated with having 
a high burden of Campylobacter infection and diarrhea.  At 6, 12 and 18m of age, 
Campylobacter spp was the only OTU that differed significantly between Campylobacter 
-positive and negative surveillance stools (p=0.005, p=0.07, p=0.028 respectively).  
However, at 24m of age, we did see a significant increase in a member of the families 
Coriobacteriaceae and Ruminococcaceae, both of which were significantly more 
abundant in and specific to Campylobacter-positive stools at 24m of age (p=0.02, p=0.03 
respectively). When assessing lifetime Campylobacter burden as the risk factor, we 
identified 23 OTU that were significantly indicative being in extreme quartiles from birth 
to two years of age.  Of these, 9 OTU were indicative of being in the low burden group at 
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6, 12 and 24m, and 14 OTU were indicative experiencing high burden at 6, 18 and 24m 
of age.   Results of the ISA comparing children in the highest and lowest quartiles of 
asymptomatic Campylobacter spp infection are shown in Table 3.  No OTU were 
identified as indicative of Campylobacter diarrhea history.    
We replicated ISA analyses for three other highly prevalent enteropathogens in the 
cohort to assess whether results were indicative of Campylobacter spp burden 
specifically, or of general enteric pathogen pressure. Surveillance stools contributed by 
children of high and low Giardia spp., entero-aggregative Escherichia coli (EAEC), and 
norovirus infection were compared at each quarter of life.  At 6m of age, we identified 
Streptococcus thermophiles as indicative of being in the lowest-burden quartile of 
norovirus infection (p=0.02).  Five OTU in total were significantly indicative of giardia 
burden throughout life; three at one year of age and two at 18m of age. No other OTU 
were identified as being indicative of EAEC, giardia or norovirus in the cohort.   
Associations between gut microbial species and metrics of child growth.   To further 
explore evidence for the hypothesis that changes to the gut microbiota may be implicated 
in the relationship between asymptomatic Campylobacter infection and child growth 
deficits, we assessed whether OTU indicative of Campylobacter burden were 
independently associated with length-for-age in this population. The presence and 
abundance of each OTU listed in Table 3 were modeled as predictors of growth 
longitudinally from birth to two years adjusting for age, LAZ at birth, pathogen pressure, 
diarrheal history, antibiotic exposure, breastfeeding and dietary diversity.  Results of 
longitudinal multivariable regression models measuring associations between the 
presence and abundance of each OTU derived from the ISA with concurrent and 
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subsequent growth (1m after stool collection) metrics from birth to two years are shown 
in Tables 4 and 5.   
While the presence of Bifidobacterium breve was nearly ubiquitous in the population, 
we observed its abundance was significantly associated with increased LAZ concurrently 
and one month later in the fully adjusted model.  Presence of B. breve was also associated 
with reduced odds of being stunted one month after stool analysis; a 10% decrease in the 
odds of stunting was associated with each additional thousand units of B. breve detected 
throughout follow-up. We observed significant evidence that the presence of 
Erysipelatoclostriudium ramosum and Ruminococcus torques, which were found to be 
significantly indicative of low Campylobacter burden at two years of age, was positively 
associated with LAZ from birth to two years of age.  In addition, abundance of E. 
ramosum was associated with increased LAZ at the time of follow-up, as well as 1m 
thereafter.  R. torques was also significantly associated with the odds of stunting; children 
in whose stools this microbe was detected had a 37% reduction in the odds of being 
stunted at 6, 12, 18 and 24m of life (β=0.63; p=0.03).   The presence of three microbes 
(Parabacteroides distasonis, Faecalibacterium paruznitzii and Senegalimassilia 
anaerobia) indicative of high Campylobacter burden at different stages of life was 
associated with significantly increased odds of being stunted at the following visit (OR 
1.40, 1.43 and 1.58 respectively).  However, we also observed increased odds of stunting 
associated with the presence of a member of the Lachnospiraceae family which was 
found to be indicative of low Campylobacter burden at 24m of age.   
We further observed suggestive trends between the presence of additional OTU and 
child growth, for which the probability of alpha error was below 10% (p<0.1).  Presence 
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of Streptococcus infantis, which was indicative of being in the low-burden quartile of 
Campylobacter infection, was marginally associated with LAZ throughout life and was 
associated with a reduction in the odds of stunting at the following visit.    Negative 
growth trends were also observed for F. prauznitzii, S. dextrinosolvens, H. biformis and a 
member of the Prevotellaceae family, all of which were indicative of the high burden 
quartile of Campylobacter infection (see Tables 4, 5).  
 
DISCUSSION. 
 This study highlights a population experiencing extremely high incidence of 
Campylobacter infections and provides evidence for the hypothesis that asymptomatic 
burden is associated with changes to the gut microbial community, which in turn may 
impact child growth. In a longitudinal birth cohort of 271 children living in a peri-urban 
tropical environment with high exposure to enteropathogens, we identify several 
individual gut microbes that are indicative of experiencing heavy Campylobacter burden 
from birth to two years of age, and identify those whose presence or abundance is 
significantly associated with subsequent linear growth gains.  
We additionally confirm previously observed relationships between clinical and 
subclinical Campylobacter infections and growth acquisition in children living in poverty 
in Peru (35,36).   
 Prior work within the Peru Microbiota collaboration (Chapter 5) has shown that the 
frequency, severity and duration of all-cause diarrhea is associated with lasting reductions 
in the acquisition of fecal microbial diversity. Here, we found no association between 
Campylobacter diarrhea with microbial diversity and richness indices, independent of all-
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cause diarrhea, nor did we identify key species indicative of recent disease.  It is possible 
that symptoms accompanying clinical diarrhea affect the overall population diversity and 
richness indiscriminately; or if particular pathogens do enact a specific effects on the gut 
community, that Campylobacter spp are not among them.  A recent study published 
results from ISA identifying numerous OTU associated with the diarrheal and recovery 
phases of Vibrio cholerae infection in Bangladesh; however, this was conducted in 
among hospitalized adults (85). Older individuals whose microbial ecosystem have 
reached a stable state may be more amenable to comparison using the ISA methodology, 
relative to infants whose gut environment is necessarily in flux during this critical 
developmental window.   More evidence on impacts of diarrhea of various etiologies in 
community settings and among infants and young children will help to clarify these 
relationships.  In addition, disaggregating all-cause diarrhea in future analyses to assess 
whether these results differ by pathogens inducing inflammatory or invasive disease is of 
interest to improving our understand of the consequences of diarrheal disease for the 
microbiota.   
 In contrast, we observed that asymptomatic Campylobacter infection is associated 
with increased alpha diversity among children age 0-2 years, independent of other 
enteropathogens.  This finding highlights the caveats of judging gut microbial “health” 
based on diversity measures alone.  In early life, increased diversity may not always be a 
marker of optimal health.  Indeed, breastmilk has been shown to exert a suppressive 
effect on diversity in the infant gut by this group and others, leading to the hypothesis 
that limited diversity in early life reflects the healthy predominance of bacteria that digest 
breastmilk and may confer resilience to external insult (86–95).  Diversity metrics are a 
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function of overall number of OTU in a sample, and of the abundance of each.  
Therefore, increased diversity and richness resulting from asymptomatic infections may 
reflect a disruption of healthy predominance of particular members of the infant gut, or 
simply the addition of Campylobacter OTU to the gut environment, increasing its overall 
species composition.  In contrast, colonization of the environment with Campylobacter, 
resulting in a reduction in the number or abundance of other members, would result in 
decreased diversity. Caveats in the interpretation of whether gut diversity denotes 
stability and resilience have led to calls for studies to broaden microbiome studies to 
evaluate multiple microbial outcomes (96).   
 In this study, we conducted additional analyses to detect possible species-level 
associations between infection and microbiota, which revealed several significant 
indicators of infection stratum. We identified thirteen OTU from four phyla that were 
indicative of being in the highest stratum of asymptomatic Campylobacter infection 
throughout the first two years of life, several of which showed suggestive or significant 
associations with growth.  Multiple OTU identified here have previously been implicated 
in pathways of inflammation and weight gain or loss, and while evidence suggests they 
are important for the modulation of immunity and metabolism, there are health 
consequences associated with both increases and decreases in their levels.  For example, 
F. prauznitzii has anti-inflammatory properties and is decreased among patients with 
inflammatory bowel diseases (IBD) (97–99), but elevated levels have been associated 
with obesity in children (100) and in weight loss during fasting (101). R. gnavus is 
common in both infant and adult populations (102,103) and has been suggested to 
promote protein synthesis by the host gut epithelium and has been associated with weight 
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gain (54); however, it is implicated in IBD when present at higher levels (104). In the 
current study, both OTU are prevalent across both infection strata, but were significantly 
more abundant in samples contributed by children experiencing the highest burden of 
asymptomatic infections, and there was some suggestive evidence that presence of F. 
prauznitzii was associated with reduced linear growth. The role of P. distasonis, also 
indicative of high infection burden, is similarly ambiguous, with prior evidence 
suggesting a role in both reduced (105) and increased inflammation (106) and colitis 
(107). P. distasonis and two more members of the phylum Bacteroidetes (unspecified 
Prevotellaceae) were indicative of high asymptomatic disease burden and associated with 
growth deficits. Finally, S. anaerobia and S. dextrinosolvens, both of which were 
associated with being stunted, are succinate-utilizing bacteria associated with high-starch, 
western diets (108–112). The mixed evidence as to benefit and harm associated with 
presence and abundance of these bacteria demonstrates that while optimal levels are not 
yet identified, these bacteria can impact both inflammatory and metabolic processes in 
the human gut. The observation that Campylobacter burden is associated with differences 
in these populations is consistent with the hypothesis that asymptomatic infection load 
may result in alterations to bacterial groups that are noted here and elsewhere to be 
associated with inflammation and growth. This would further support the EE hypothesis; 
however, data presented here are insufficient to confirm any precise causal mechanisms.  
Remaining OTU that emerged as having a potential relationship to growth were largely 
absent in the literature.   
We identified nine OTU indicative of being in the low-burden stratum of 
asymptomatic Campylobacter infection, the majority of which were butyrate-producing 
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Firmicutes.  Butyrate is a short-chain fatty acid produced by the fermentation of fiber in 
the colon, and a documented energy source for colonocytes associated with improved gut 
barrier integrity and with well documented anti-inflammatory activity (113–115).  Some 
of these species, such as A. hadrus and E. ramosum, have nonetheless been associated 
with undesirable health outcomes such as obesity (116) and diarrhea-predominant IBS 
(117). We also noted that while B. breve and B. fragilis, both adept at metabolizing 
breastmilk (118), were significantly more abundant in low-burden group at 6 and 12 
months, respectively.  Exclusive breastfeeding was significantly protective against 
Campylobacter infection in the MAL-ED study (36), and it is possible that this finding is 
reflective of the greater protection enjoyed by infants whose diet was still largely 
composed of breastmilk in early life..  
Results should be viewed in light of several methodological limitations.  First, we 
were unable to conduct species-level analyses of Campylobacter infections.  However, 
given the considerable underestimation of infection by culture detection, which this 
parent study brought to light (40), we opted to accept this caveat and rely on ELISA 
methodology to capture the greatest proportion of infection in the population.  In light of 
recent evidence that a broader range of species can cause morbidity than previously 
known (42), future work should consider whether different species of Campylobacter 
may have distinct consequences for the gut environment and subsequent inflammatory or 
metabolic sequelae.  Our reliance on 16S rRNA data to differentiate gut microbe species 
precluded us from measuring genomic markers or drawing any inference regarding the 
function of microbial populations affected by Campylobacter infection.  Whole genome 
sequencing should be considered in future studies describe to functional and metabolic 
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profiles of the microbiota and gain a more complete understanding of the functions that 
may be affected by infection burden (119).  Finally, ISA is one of many methods 
assessing OTU-level changes in the gut.  This work did not interrogate patterns of beta-
diversity nor employ alternate OTU-level methodologies to assess changes to broader gut 
bacterial populations.   
Nonetheless, we illustrate changes to gut microbial populations associated with 
asymptomatic Campylobacter infections in a longitudinal study with a large sample size 
and generate testable hypotheses to improve control of this highly prevalent 
enteropathogen and mitigate its adverse effects on growth in infancy and early childhood.  
The demonstration that alterations in gut microbial populations associated with 
Campylobacter is independent from diarrhea-related purging and accelerated transit of 
upper gut flora is notable, as are the findings that different enteropathogens appear to 
have consistent and differing effects on diversity and membership of the microbial 
community.  These data can inform translational research in order to guide novel 
interventions. 
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Table 1: Cumulative Campylobacter spp history among 271 children in Peru demonstrates nearly 
universal asymptomatic infection and considerable burden of diarrheal disease from 0-24m of age 
Campylobacter infection & 
diarrhea 
6m 12m 18m 24m 
     
     
Proportion of children ever 
infected 
46.5 (126) 76.0 (206) 77.1 (209) 92.6 (251) 
Proportion of children ever 
experiencing Campylobacter 
diarrhea  
26.2 (71) 57.6 (156) 69.7 (189) 81.6 (221) 
Mean (range) of 
Campylobacter-positive 
diarrheal episodes by ELISA 
 
0.26 (0-4) 0.97 (0-4) 1.9 (0-11) 2.6 (0-15) 
     
Mean (SD) proportion of 
surveillance stools per child 









Mean (SD) proportion of 
diarrheal samples collected 
























Table 2: Symptomatic and asymptomatic Campylobacter infections and community-level microbial 
indices 
 Mean microbial metric 
β (SE); 95% confidence interval 




(per 10% increase in 











0.13 (0.03)  
0.06, 0.19 
     





































Models are adjusted for age, breastfeeding frequency, category, pathogen pressure excluding 
Campylobacter and antibiotic exposure.  Additional adjustment for 1proportion of surveillance stools 
infected with other enteropathogens, 2number of Campylobacter-negative diarrheal episodes experienced, 3 
severity and 4duration of Campylobacter-negative diarrhea was conducted in each model, respectively, to 
assess whether Campylobacter infection and diarrhea were independently associated with microbial 
indices.  
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Table 3: Operational taxonomic units significantly associated with asymptomatic Campylobacter burden in the Peru Microbiota Collaboration 
Age bin Indicator Value Specificity Fidelity OTU Adj. p-value 
 I.Low I.High A.Low A.High B.Low B.High  
 6 0.00 0.20 0.01 0.99 0.01 0.20 Campylobacter jejuni 0.009 
6 0.04 0.35 0.21 0.79 0.21 0.44 Ruminococcus gnavus 0.031 
6 0.01 0.21 0.07 0.93 0.08 0.22 Parabacteroides distasonis 0.031 
6 0.61 0.34 0.64 0.36 0.96 0.94 Streptococcus infantis 0.031 
6 0.54 0.46 0.54 0.46 1.00 1.00 Bifidobacterium breve 0.040 
12 0.39 0.02 0.85 0.15 0.46 0.12 Bacteroides fragilis 0.017 
18 0.06 0.48 0.21 0.79 0.31 0.60 Faecalibacterium prausnitzii 0.029 
18 0.00 0.24 0.04 0.96 0.03 0.25 Lysobacter b01 0.029 
24 0.07 0.57 0.25 0.75 0.27 0.76 Uncultured catenibacterium  0.006 
24 0.00 0.29 0.10 0.90 0.04 0.32 Prevotellaceae 0.006 
24 0.00 0.35 0.02 0.98 0.02 0.36 Prevotellaceae 0.006 
24 0.01 0.43 0.10 0.90 0.14 0.48 Holdemanella biformis 0.013 
24 0.00 0.37 0.02 0.98 0.12 0.38 Succinivibrio dextrinosolvens 0.020 
24 0.15 0.56 0.30 0.70 0.49 0.80 Senegalimassilia anaerobia 0.029 
24 0.00 0.26 0.06 0.94 0.06 0.28 Coriobacteriaceae 0.038 
24 0.02 0.34 0.15 0.85 0.14 0.40 Phascolarctobacterium succinatutens 0.046 
24 0.08 0.53 0.22 0.78 0.35 0.68 Unknown  0.050 
24 0.52 0.02 0.92 0.08 0.57 0.24 Erysipelatoclostridium ramosum 0.006 
24 0.42 0.02 0.88 0.12 0.47 0.14 Clostridium 0.006 
24 0.39 0.00 0.96 0.04 0.41 0.04 Ruminococcus torques 0.006 
24 0.57 0.14 0.74 0.26 0.76 0.54 Lachnospiraceae 0.010 
24 0.37 0.02 0.89 0.11 0.41 0.16 Lachnospiraceae 0.029 
24 0.69 0.29 0.70 0.30 0.98 0.98 Anaerostipes hadrus 0.038 
I variables columns denote indicator values for children in the lowest and highest strata of infection; A (Specificity) is the mean relative abundance of a 
particular OTU in the lowest and highest strata, normalized to the sum of the means in both strata; B (Fidelity) denotes the total proportion of stools 
from children in low and high burden groups in which each OTU is present. Species indicative of high and low burden are shown in red and green 
respectively 
 147 
Table 4: Associations between specific OTU and length-for-age Z-score in the Peru Microbiota Collaboration 
 OTU identified in ISA 
Presence 
β; p-value   
Abundance 
β; p-value   
  LAZ LAZ + 1m LAZ  LAZ + 1m 
Ruminococcus_gnavus <0.01; 0.969 0.04; 0.220 <0.01;0.760 <0.01; 0.711 
Parabacteroides_distasonis -0.04; 0.346 -0.03; 0.429 <0.01; 0.919 <0.01; 0.651 
Streptococcus_infantis  0.11; 0.052 0.06; 0.202 <0.01; 0.925 -0.01; 0.829 
Bifidobacterium_breve  NA NA <0.01; 0.045 0.01; 0.001 
Bacteroides_fragilis 0.03; 0.589 <0.01; 0.942 1.83; 0.247 0.44; 0.750 
Faecalibacterium_prausnitzii -0.09; 0.074 -0.06; 0.136 -1.13; 0.174 -0.60; 0.411 
Lysobacter  -0.01; 0.871 -0.01; 0.908 <0.01; 0.954 0.02; 0.691 
Catenibacterium 0.01; 0.865 0.06; 0.219 0.02; 0.567 0.01; 0.625 
Prevotellaceae -0.14; 0.100 -0.05; 0.485 -0.09; 0.165 -0.03; 0.623 
Prevotellaceae -0.14; 0.063 -0.10; 0.114 -0.13; 0.371 0.01; 0.916 
Holdemanella_biformis -0.05; 0.449 -0.07; 0.248 -0.02; 0.604 -0.03; 0.478 
Succinivibrio_dextrinosolvens -0.12; 0.068 -0.05; 0.363 -0.01; 0.284 <0.01; 0.683 
Senegalimassilia_anaerobia -0.02; 0.664 -0.05; 0.237 0.145; 0.222 0.06; 0.594 
Coriobacteriaceae -0.09; 0.234 -0.06; 0.360 0.31; 0.711 0.34; 0.647 
Phascolarctobacterium_succinatutens -0.09; 0.194 -0.04; 0.508 -0.14; 0.422 0.01; 0.949 
Unknown  0.02; 0.727 0.02; 0.794 0.08; 0.141 0.01; 0.784 
Erysipelatoclostridium_ramosum 0.10; 0.011 0.07; 0.065 0.10; 0.009 0.09; 0.007 
Clostridium <0.01; 0.960 0.03; 0.558 0.08; 0.937 1.32; 0.136 
Ruminococcus_torques 0.12; 0.039 0.08; 0.119 0.04; 0.700 0.01; 0.874 
Lachnospiraceae -0.02; 0.715 -0.05; 0.248 -0.21; 0.799 -0.83; 0.254 
Lachnospiraceae -0.03; 0.625 -0.02; 0.713 0.57; 0.634 1.29; 0.222 
Anaerostipes_hadrus -0.04; 0.443 -0.07; 0.115 0.01; 0.402 <0.01; 0.710 
Results of multiple regression modeling association between presence and abundance of OTU on current and subsequent LAZ.  OTU are color-coded to 
represent association with being in the high burden (red) and low burden (green) groups and listed in the same order as Table 3. Models are adjusted 
for age, LAZ at birth, breastfeeding, antibiotic exposure, dietary diversity, pathogen pressure and diarrheal disease.  
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Table 5: Associations between specific OTU and odds of being stunted in the Peru Microbiota Collaboration 
 OTU identified in ISA 
Presence 
Odds ratio; p-value 
Abundance 




Stunting at next 
visit (+1m) 
Stunting at current 
visit 
Stunting at next 
visit (+1m) 
Ruminococcus_gnavus 1.00; 0.980 0.88; 0.384 1.02; 0.386 1.02; 0.303 
Parabacteroides_distasonis 1.23; 0.148 1.40; 0.025 0.92; 0.460 0.97; 0.763 
Streptococcus_infantis  0.77; 0.171 0.72; 0.084 1.00; 0.961 1.07; 0.540 
Bifidobacterium_breve  NA NA 1.00 ;0.143 0.99; 0.002 
Bacteroides_fragilis 1.18; 0.352 1.22; 0.255 >100; 0.384 >100; 0.134 
Faecalibacterium_prausnitzii 1.12; 0.493 1.43; 0.03 4.98 0.581 32.34; 0.233 
Lysobacter  0.88; 0.582 0.90; 0.659 0.65; 0.242 0.64; 0.238 
Catenibacterium 1.03; 0.892 1.02; 0.904 1.09; 0.361 1.11; 0.239 
Prevotellaceae 1.18; 0.551 1.16; 0.605 1.38; 0.315 1.10; 0.679 
Prevotellaceae 1.62; 0.053 1.43; 0.155 2.03; 0.147 1.31; 0.591 
Holdemanella_biformis 1.32; 0.32 1.57; 0.061 1.10; 0.547 1.22; 0.232 
Succinivibrio_dextrinosolvens 1.48; 0.068 1.50; 0.059 1.01; 0.880 1.01; 0.827 
Senegalimassilia_anaerobia 1.37; 0.056 1.58; 0.005 0.88; 0.766 0.81; 0.614 
Coriobacteriaceae 1.12; 0.663 1.25; 0.385 0.48; 0.821 1.36; 0.922 
Phascolarctobacterium_succinatutens 1.20; 0.413 1.05; 0.844 2.03; 0.209 1.40; 0.547 
Unknown  0.98; 0.938 0.86; 0.478 0.77; 0.236 0.76; 0.213 
Erysipelatoclostridium_ramosum 0.81; 0.143 0.79; 0.104 0.66; 0.189 0.65; 0.183 
Clostridium 0.90; 0.583 0.87; 0.463 54.27; 0.231 0.78; 0.939 
Ruminococcus_torques 0.63; 0.030 0.81; 0.297 0.77; 0.407 0.77; 0.425 
Lachnospiraceae 1.34; 0.086 1.54; 0.012 6.42; 0.515 54.96; 0.151 
Lachnospiraceae 0.98; 0.917 1.14; 0.504 2.99; 0.776 0.04; 0.408 
Anaerostipes_hadrus 1.20; 0.346 1.33; 0.123 1.03; 0.500 1.01; 0.841 
Results of multiple regression modeling association between presence and abundance of OTU on current and subsequent stunting.  OTU are color-
coded to represent association with being in the high burden (red) and low burden (green) groups and listed in the same order as Table 3. Models are 
adjusted for age, LAZ at birth, breastfeeding, antibiotic exposure, dietary diversity, pathogen pressure and diarrheal disease.  
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Chapter 7: Discussion 
Summary of key findings 
This dissertation sought to contribute evidence of the hypothesis that disruptions to 
the gut microbiota of infants living in poverty are implicated in the observed cycle of 
enteric infections, diarrhea and undernutrition they experience.  We employed 
longitudinal methods to generate population-averaged estimates of associations between 
metrics of gut microbial maturity, diversity, richness, and presence and abundance of 
particular taxa with anthropometric indices, diarrheal disease, and Campylobacter 
infections in the largest longitudinal birth cohort interrogating these relationships to date.  
This work adds to the literature describing the impacts of age, breastfeeding habits, 
and dietary diversity on the bacterial composition of the developing infant gut. Our data 
supports the previously reported finding that the gut microbial community is suppressed 
by breastmilk in early life, even in the presence of complementary foods, and then 
undergoes rapid expansion upon weaning. We employ metrics collected through active 
surveillance that produce near-daily recall and generate detailed dietary and illness 
histories. In addition to analyzing trends according to traditional breastfeeding categories, 
we measured frequency of exposure to breastmilk, and found a significant suppressive 
effect on gut microbial diversity and richness independent of whether children were 
exclusively breastfed.  The use of novel metrics to support prior observations, the 
frequency of longitudinal measurements, and the large sample size of this cohort allowed 
us to conduct descriptive analyses that represent an important contribution to the 
literature, independent of any hypothesis-testing.   
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We observed suggestive evidence supporting the prior observations that gut microbial 
maturity, determined by the presence of age-discriminatory taxa in children with healthy 
growth acquisition, was associated with subsequent weight gain in our population.  
However, we noted that this cohort was born with and continued to exhibit considerably 
higher weight-for-length than other populations in which this relationship was observed.  
Whether this reflects the growing epidemic of overweight and obesity across Latin 
America (1), or the short  length and height characteristic of populations with 
compounded intergenerational stunting, cannot be deduced from this data.  However, we 
did observe significant evidence of interaction between stunting and wasting, with higher 
weight-for-length associated with lower length-for-age, which provides support for the 
latter explanation. In the small subset of children who experienced wasting in this 
population, we detected pronounced linear growth faltering and a distinct relationship 
between length-for-age and gut microbial maturity. These data suggest that the gut 
microbial environment may be reflective of co-occurring and interacting mechanisms 
driving different nutritional phenotypes.  
Our efforts to identify gut microbial markers of linear growth failure did not reveal 
distinct patterns of microbial maturity, diversity or richness among children with 
postnatal growth faltering.  However, we did identify significant differences in these 
metrics among children who were born stunted, a condition likely reflective of maternal 
nutrition both prior to and during gestation (2,3). Children born with intrauterine growth 
restriction have been identified as a particularly vulnerable subpopulation with 
significantly increased risk of neonatal and infant mortality (4), as well as continued 
stunting (5) and its long-term consequences (6).  Indeed, the prenatal growth environment 
 158 
is estimated to underlie one fifth of all childhood stunting worldwide (5).  We report that 
LAZ at birth was significantly positively predictive of microbial maturity through two 
years of age, demonstrating that acquisition of age-appropriate taxa that may be involved 
in weight gain is compromised in this subgroup.  This subgroup of children also 
experienced significantly compromised trajectories of overall diversity and richness 
acquisition, with pronounced deficits observed among those children weaned before two 
years of age.   
Together, these observations have implications for transferability of findings between 
populations.  Studies assessing relationships between microbial metrics and child growth, 
particularly linear growth, have enrolled participants with co-occurring ponderal deficits 
and have not stratified by, or adjusted for, anthropometric indices at birth.  Our data 
suggest that extrapolating results between populations with different nutritional histories 
and phenotypes may be invalid, and underscores the need for studies with larger sample 
sizes that permit stratification of sub-groups and testing of interactions to help elucidate 
the interplay between length and weight acquisition and the intestinal environment more 
clearly. Our findings also have programmatic implications for the global health 
community.  While it is not yet clear whether and how microbial populations may be 
manipulated in effort to ameliorate growth, our findings suggest that more emphasis be 
placed on the existing WHO recommendation of continuing breastfeeding to two years of 
age to mitigate the gut microbial consequences of insults, particularly among high-risk 
groups.  This recommendation was omitted from recent global nutrition targets (7); work 
presented here adds further weight to the body of evidence suggesting that duration and 
not just exclusivity of breastfeeding should be promoted (8).   
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Given the growing body of evidence supporting associations between the gut 
microbial community and child growth, to which this study contributed, the subsequent 
components of our work aimed to test hypotheses that the gut environment is impacted by 
enteric infection and disease. In a population experiencing the classical cycle of diarrhea 
and undernutrition, we observed significant reductions in microbial diversity acquisition 
with increasing frequency, duration and severity of diarrhea, and detected an association 
between lower gut diversity and increased incidence of diarrheal episodes thereafter 
(Chapter 5).  We further report that apparent consequences of diarrheal disease for the gut 
environment can endure beyond one month, and that diversity and richness regenerate 
with increasing time since last insult. While this work was not designed to assess 
causality, our data illustrate that the microbial community can be impacted in an additive 
and enduring manner by repeated episodes of diarrheal disease, and that these 
consequences either cause further vulnerability to disease or are reflective of some 
underlying mechanism that does. This is the first study to our knowledge that has 
illustrated this relationship in the context of community-based diarrheal disease in a 
population with endemic undernutrition. Findings from the first aim of this work 
(Chapter 4) informed a specific interrogation of whether observed associations differed 
according to different linear growth profiles.  We identified significantly greater impact 
of diarrheal insults on the gut environment of children born stunted, and observed 
reductions in the rate at which diversity and richness measures recovered post-diarrhea 
among children with severe stunting. These data further support the evolving hypothesis 
that the gut microbial community is involved in the interface between diarrheal disease 
and child growth.   
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In an effort to evaluate evidence of the role of gut microbiota as a component of 
environmental enteropathy, we characterized patterns of diversity, richness, and presence 
and abundance of bacterial taxa during symptomatic and asymptomatic Campylobacter 
detection (Chapter 6). Infection with Campylobacter spp. is thought to be an illustrative 
example of the EE hypothesis for multiple reasons: it is increasingly understood to drive 
undernutrition and induce long-term inflammatory and immunological dysfunction, and 
has been linked to alterations in intestinal permeability and immunotolerance, even in the 
absence of symptoms (9–17). Prior studies have made important contributions to the 
understanding of Campylobacter epidemiology, demonstrating infection to be associated 
with significant subsequent linear growth faltering, and employing novel diagnostics to 
reveal high prevalence of a wider range of Campylobacter species than previously 
appreciated (18–22).  Among the 271 children enrolled in the Peru Microbiota 
Collaboration, we report nearly universal detection of Campylobacter in asymptomatic 
stools, and over 80% prevalence in diarrheal samples from birth to two years of age. 
Given the well-characterized long-term sequealae of Campylobacter spp. across 
epidemiologic settings, this is a staggering burden of infection and illness.  We observed 
evidence that asymptomatic Campylobacter carriage had significant, independent impacts 
on the gut microbial diversity and richness.  Furthermore, we identified 21 specific taxa 
that were statistically indicative of being in the highest or lowest quartiles of infection 
burden throughout follow-up, seven of which were associated with length-for-age.  
Notably, we did not observe as many indicators of other key infections (Giardia spp., 
entero-aggregative Escherichia coli (EAEC), and norovirus) in the population, nor did 
the taxa overlap with those indicative of these other infections.   
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Taken together, Chapters 5 and 6 of this dissertation contribute relevant insights to 
ongoing efforts to disentangle relationships between diarrheal disease, asymptomatic 
infection, and their intestinal, immunological and systemic consequences.  First, we 
demonstrate that morbidity driven by all-cause diarrhea should not be dismissed as the 
global health community shifts its focus to EE; while asymptomatic infections, gut 
permeability and inflammation have clearly emerged as significant components of child 
health, the physical insult of diarrhea still has important consequences beyond 
symptomatic illness.  Our data show that purging of the gut microbial community that 
occurs with diarrheal disease, and particularly severe, enduring, or repeated disease, may 
result in lasting changes to gut diversity and richness.  Nonetheless, we also provide 
evidence supporting supposed pathways of the EE hypothesis.  Gut microbiota were 
identified as correlates of both asymptomatic Campylobacter infection and child growth 
in a population in whom Campylobacter is significantly associated with linear deficits.  
This finding suggests that at a minimum, changes to particular taxa are markers of the 
posited relationships between Campylobacter and stunting in this community; whether 
microbiota are on the causal pathway between these conditions remains to be determined. 
That different enteropathogens may elicit distinct changes to the gut community is an 
important finding with implications for the design of interventions. If pathogens have 
different impacts on the gut environment, optimal probiotic compounds will be 
challenging to design, particularly in communities like Santa Clara with a high 
prevalence of co-infections.  Analysis of OTU-level consequences of an array of 
enteropathogens must be done in order to provide a more comprehensive description of 
whether and where affected taxa overlap, and importantly whether supplementation 
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designed to encourage expansion of particular groups does not put children at risk of 
infection, colonization, or pathogenesis with other enteropathogens in circulation.  
Methodological and analytic contribution 
This study was unique in its methodological and analytic approach, which merits 
some commentary.  We sought to replicate findings that a novel metric of gut microbial 
maturity was related to wasting among children in LMIC, and assess whether this marker 
was also sensitive to variations in linear growth. We observed very little variation in the 
MAZ marker in this cohort, despite the progressive linear growth faltering they 
experienced.  There are various explanations for this negative finding.  It is possible that 
age-discriminatory taxa are not related to linear growth acquisition as strongly as they are 
to weight gain.  It is also possible that the calculation of the metric should be adapted to 
better discriminate gut flora between children of different growth trajectories. Children 
selected to create the standard reference group for microbial maturity were included on 
the basis of never experiencing WLZ or LAZ below -1.75; while this cutoff may be 
discriminatory for weight in a population with low stunting, it may not be the optimal 
cutoff to identify taxa that can appropriately discriminate between different linear growth 
trajectories.   
Nonetheless, the use of methods such as random forests to help reduce the multitude 
of gut microbial data and identify discriminatory taxa will be important to the continuing 
efforts to identify specific, actionable targets of the gut microbial community that may be 
implicated in driving undesirable phenotypes. This is particularly true in light of the 
challenges of relying on judging microbial health as a function of diversity, especially in 
the context of the rapid changes occurring during infancy. This work, while contributing 
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valuable evidence to characterize patterns of diversity acquisition and its determinants in 
early childhood, also serves to illustrate these challenges.  For example, our observations 
of significant and enduring deficits in diversity and richness among children with high 
diarrheal disease burden, children born stunted, or those weaned before the recommended 
threshold of 24m suggest that deficits confer or reflect negative health outcomes.  Indeed, 
loss of species diversity has been observed in other negative health states in microbiome 
research.  In contrast, the suppressive effects of breastmilk on diversity richness, and the 
observation that asymptomatic infections increase these metrics, run counter to the 
narrative that a more diverse gut community is automatically a more resilient one. 
Furthermore, focusing solely on outcomes to overall metrics of diversity and richness 
limit opportunities for intervention design; identification of particular taxa that may be 
conducive to growth or immunity to infection is a necessary step to eventually design 
clinical interventions. On the other hand, the extraordinary amount of data produced in 
studies of gut microbial composition and function makes it difficult and infeasible to 
conduct detailed analyses at the species level across populations with differing dietary 
and environmental exposures, especially in lower-resource settings. As in all 
epidemiologic enquiries, there is no single marker or outcome that can be employed to 
satisfy the many research questions and objectives of this novel field.  However, we 
would argue that in this context, the approach underlying the MAZ score is a very 
promising one.  By identifying taxa that are discriminatory and predictive of various 
phenotypes, this metric incorporates both community-wide and species-level information.  
That we did not find this metric to be informative of postnatal linear acquisition in our 
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cohort should provide impetus to reevaluate the parameters used in its calculation and to 
develop and test it further, rather than to dismiss it.   
Finally, we note that this study sought to analytically diversify the landscape of 
evidence as to the clinical potential of manipulating the microbiota to improve population 
health.  The predominance of cross-sectional studies and panel studies with a focus on a 
small number of participants has been useful and appropriate for several important 
reasons. The prohibitive costs of analyzing gut microbial metrics data has, until recently, 
limited the feasibility of conducting longitudinal studies with large samples sizes. For 
measures with a high degree of within-person variation, detailed chronicling of trends in 
a single individual across multiple time points is highly informative. This individual 
panel design has and will continue to be invaluable to informing translational studies in 
mice, and studying clinical progression of different gut microbial characteristics.  
Complementary work describing and comparing microbial features between individuals 
and communities have been derived from studies enrolling with larger sample sizes, but 
these have largely been cross-sectional.  Together, in vitro and animal models, panel 
studies, and cross-sectional studies have complemented each other to generate novel 
hypotheses; however, assessing evidence for these hypotheses in large, longitudinal 
studies is a necessary next step in the process of epidemiologic enquiry and is crucial to 
understanding whether we can anticipate population-level health impacts from ensuing 
research and intervention design.  An important overarching aim of this work was 
therefore to provide a complementary analytical approach to the existing landscape, and 
inform further iterations of these different types of studies.  We did identify population 
level trends in diversity acquisition, deficit, and rates of regeneration across a large 
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sample of vulnerable children; however, we acknowledge that this work was still largely 
hypothesis-generating in nature and should inform further translational models to aide in 
causal inference and in turn provide a justification and basis for the design of therapeutic 
compounds.  Our collaboration with the Gordon Laboratory will permit the extension of 
our findings to inform experimental animal models.  More collaborations with 
translational as well as epidemiologic components which can continually inform each 
other in an iterative fashion will be useful to facilitate the eventual goal of delivering 
tools for the improvement of child health and survival, particularly in vulnerable 
communities.  
Limitations 
Findings and contributions must be interpreted in light of several limitations. Gut 
microbial taxa were identified using PCR primers identifying the V4 region of ribosomal 
RNA; this methodology has been standard in the literature to date, but its limitations are 
well documented and recent advances enable more comprehensive and less biased 
methods.  Specifically, the limited precision in identifying bacteria at the species level, as 
evidence by some of the unknown species emerging in our indicator species analyses, 
may have precluded us from identifying important taxa.  The risk of bias towards 
amplifying genes from particular groups over others, and the estimation of the 
phylogenetic diversity of an entire organism based on only one gene segment, may have 
produced biased estimates of diversity and richness.  Whole-genome sequencing should 
be employed for future studies in order to improve precision as well as expand analyses 
to characterizing metabolomic and proteomic functions of microbial populations in the 
human gut, which have been shown to be more preserved across geographic settings than 
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bacterial populations (23).  This approach, we expect, will better advance our 
understanding of whether and how gut microbes may be causally implicated in the 
relationships observed.  
Despite the uniquely comprehensive dataset available to us, there remain variables of 
interest that we did not measure in this study.  First, the absence of microbial measures at 
birth or enrollment precludes us from understanding temporality of gut microbial and 
enteropathogen incidence in early life. Second, while the parent study did collect markers 
of gut inflammation and permeability, the timing of collection was not coordinated with 
objective of the Peru Microbiota Collaboration, and this prevented us from conducting 
longitudinal analyses of gut microbial markers and markers of EE. Third, given the 
relevance of maternal nutrition and microbiota to establishing the infant gut environment, 
our lack of consideration of these variables prevents us from accounting for features that 
have been demonstrated to be related both to our exposures and our outcomes. Fourth, 
given the volatility of the microbial community in this age bracket, more frequent 
measures of gut microbial indices would aide in understanding temporal relationships and 
informing causal inference.  Ideally, we would have metrics derived for all monthly 
surveillance stools to align with our detection of asymptomatic carriage and 
anthropometric measurements.  Nonetheless, quarterly sampling on this large of a 
population represents a considerable advance in the literature.  Fifth, this study enrolled 
271 children, only 200 of whom were still under follow-up at endline.  Loss to follow-up 
is a common limitation of cohort studies, and in this community it has been noted to 
occur among children with less stable housing and food availability whose families 
migrate up and down the river according to the availability of resources.  As such, we risk 
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excluding the most vulnerable participants in our catchment area from final analyses, 
which threatens to bias our results.  Finally, the generalizability of this work is likely 
limited by various factors.  Children in this community have distinct dietary and infection 
histories relative to other settings in LMIC; that these have been chronicled in detail and 
compared with seven other settings with similar experiences of enteropathy and 
undernutrition, however, is an attribute conferred by our ability to nest this analysis 
within a global multi-site consortium (MAL-ED).  Generalizability may be more 
challenging than many other areas of research, given the profound impacts of differential 
dietary habits on bacterial populations.  We therefore reiterate that future analyses should 
assess functional profiles of gut taxa, rather than species composition alone.  
Recommendations for future research 
Our study provided evidence of the hypothesized involvement of the gut microbiota 
in the cycle of enteric infection, illness, and undernutrition among young children at the 
population level who exhibit high prevalence of stunting and enteropathy.  The findings 
described generate further questions regarding the precise causal mechanisms underlying 
the observed associations, and the determination of specific and actionable targets to 
interrupt pathways compounding childhood morbidity and mortality in LMIC. This work 
should inform the expansion of these analyses to include other sites in the MAL-ED 
study, a unique opportunity to use shared study design, diagnostic approaches, and 
methodology to compare large longitudinal cohorts across multiple settings in South 
Asia, Sub-Saharan Africa and Latin America. Assessing the utility of the microbial 
maturity marker in these other populations will help to clarify whether our observations 
were a function of the metric itself or the distribution of weight and length in our cohort. 
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Similarly, assessing whether compromised diversity acquisition or regeneration among 
children with intrauterine growth restrictions or severe stunting is replicated in other 
settings can help verify whether these are generalizable or specific to this population.  
Furthermore, translational animal studies can help to clarify whether observed 
microbial community patterns or specific taxa are causally associated with increased 
diarrheal incidence or growth failure.  For example, given the observation that children 
born stunted are compromised in their ability to diversify their gut environment, 
particularly upon weaning, fecal microbiota harvested from their feces may be used to 
inoculate mice and observe subsequent nutrient harvest and ecological expansion, in the 
presence and absence of breastmilk. Similarly, taxa identified as indicative of high or low 
Campylobacter infection strata can be used to murine or porcine models to observe their 
potential impacts on growth acquisition. Finally, we recommend a more detailed analysis 
of differential effects of dietary components and the timing of their introduction on the 
gut environment.  For the purposes of this work, dietary diversity was largely included as 
a potential confounder in order to assess evidence of independent relationships between 
infection, diarrhea, and the microbiota; however, the wealth of data collected in the 
parent study would allow detailed analysis of how exposure to different food groups and 
sufficiency of micro and macronutrients can mitigate or exacerbate unfavorable patterns 
of gut microbial assembly and function in early life. Informing these subsequent analyses 
is an important output of this project.    
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